|
Physician perceptions, attitudes, and strategies towards implementing guideline-directed medical therapy in heart failure with reduced ejection fraction. A survey of the Heart Failure Association of the ESC and the ESC Council for Cardiology Practice.
|
Eur J Heart Fail
38515385
|
0 |
18.2 |
2024 |
|
Integration of implantable device therapy in patients with heart failure. A clinical consensus statement from the Heart Failure Association (HFA) and European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC).
|
Eur J Heart Fail
38269474
|
0 |
18.2 |
2024 |
|
Quality of life endpoints in cancer cachexia clinical trials: Systematic review 3 of the cachexia endpoints series.
|
J Cachexia Sarcopenia Muscle
38553255
|
0 |
8.9 |
2024 |
|
Exercise-based cardiac rehabilitation for adults with heart failure.
|
Cochrane Database Syst Rev
38451843
|
0 |
8.4 |
2024 |
|
Epidemiology and risk factors for hyperkalaemia in heart failure.
|
ESC Heart Fail
38439165
|
0 |
3.8 |
2024 |
|
[2023 Focused update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure].
|
G Ital Cardiol (Rome)
38410903
|
0 |
0 |
2024 |
|
2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes.
|
Eur Heart J
37622663
|
38 |
39.3 |
2023 |
|
Participation in a clinical trial is associated with lower mortality but not lower risk of HF hospitalization in patients with heart failure: observations from the ESC EORP Heart Failure Long-Term Registry.
|
Eur Heart J
36879413
|
0 |
39.3 |
2023 |
|
Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes : A Mediation Analysis.
|
Ann Intern Med
38048573
|
2 |
39.2 |
2023 |
|
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.
|
Eur Respir J
36028254
|
145 |
24.3 |
2023 |
|
Clinical and Prognostic Relevance of Cardiac Wasting in Patients With Advanced Cancer.
|
J Am Coll Cardiol
37076211
|
3 |
24 |
2023 |
|
Patient phenotype profiling in heart failure with preserved ejection fraction to guide therapeutic decision making. A scientific statement of the Heart Failure Association, the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of Hypertension.
|
Eur J Heart Fail
37461163
|
3 |
18.2 |
2023 |
|
Prevalence, clinical characteristics and outcomes of heart failure patients with or without isolated or combined mitral and tricuspid regurgitation: An analysis from the ESC-HFA Heart Failure Long-Term Registry.
|
Eur J Heart Fail
37365841
|
0 |
18.2 |
2023 |
|
Diagnosis and management of patients with left ventricular hypertrophy: Role of multimodality cardiac imaging. A scientific statement of the Heart Failure Association of the European Society of Cardiology.
|
Eur J Heart Fail
37581253
|
2 |
18.2 |
2023 |
|
Acute heart failure and valvular heart disease: A scientific statement of the Heart Failure Association, the Association for Acute CardioVascular Care and the European Association of Percutaneous Cardiovascular Interventions of the European Society of Cardiology.
|
Eur J Heart Fail
37312239
|
1 |
18.2 |
2023 |
|
Autonomic and respiratory consequences of altered chemoreflex function: clinical and therapeutic implications in cardiovascular diseases.
|
Eur J Heart Fail
36907827
|
1 |
18.2 |
2023 |
|
Heart failure diagnosis in the general community - Who, how and when? A clinical consensus statement of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).
|
Eur J Heart Fail
37368511
|
1 |
18.2 |
2023 |
|
Interaction of heart failure and stroke: A clinical consensus statement of the ESC Council on Stroke, the Heart Failure Association (HFA) and the ESC Working Group on Thrombosis.
|
Eur J Heart Fail
37905380
|
0 |
18.2 |
2023 |
|
Rationale and design of the ESC Heart Failure III Registry - Implementation and discovery.
|
Eur J Heart Fail
37990135
|
0 |
18.2 |
2023 |
|
European Society of Cardiology Core Curriculum for cardio-oncology.
|
Eur J Heart Fail
38059343
|
0 |
18.2 |
2023 |
|
Patient profiles in heart failure with reduced ejection fraction: Prevalence, characteristics, treatments and outcomes in a real-world heart failure population.
|
Eur J Heart Fail
37210605
|
0 |
18.2 |
2023 |
|
Decongestion strategies in patients presenting with acutely decompensated heart failure: A worldwide survey among physicians.
|
Eur J Heart Fail
37565377
|
1 |
18.2 |
2023 |
|
Inotropic therapy in patients with advanced heart failure. A clinical consensus statement from the Heart Failure Association of the European Society of Cardiology.
|
Eur J Heart Fail
36847113
|
0 |
18.2 |
2023 |
|
Natriuretic peptides: role in the diagnosis and management of heart failure: a scientific statement from the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society.
|
Eur J Heart Fail
37098791
|
1 |
18.2 |
2023 |
|
Personalized care of patients with heart failure: are we ready for a REWOLUTION? Insights from two international surveys on healthcare professionals' needs and patients' perceptions.
|
Eur J Heart Fail
36823770
|
1 |
18.2 |
2023 |
|
Pre-discharge and early post-discharge management of patients hospitalized for acute heart failure: A scientific statement by the Heart Failure Association of the ESC.
|
Eur J Heart Fail
37448210
|
1 |
18.2 |
2023 |
|
Incidence, risk assessment and prevention of sudden cardiac death in cardiomyopathies.
|
Eur J Heart Fail
37905371
|
0 |
18.2 |
2023 |
|
Exercise-based cardiac rehabilitation for adults with heart failure - 2023 Cochrane systematic review and meta-analysis.
|
Eur J Heart Fail
37850321
|
0 |
18.2 |
2023 |
|
The small molecule ACM-001 improves cardiac function in a rat model of severe cancer cachexia.
|
Eur J Heart Fail
36999379
|
3 |
18.2 |
2023 |
|
State-of-the-art document on optimal contemporary management of cardiomyopathies.
|
Eur J Heart Fail
37470300
|
0 |
18.2 |
2023 |
|
Worsening of chronic heart failure: definition, epidemiology, management and prevention. A clinical consensus statement by the Heart Failure Association of the European Society of Cardiology.
|
Eur J Heart Fail
37208936
|
5 |
18.2 |
2023 |
|
Hyponatraemia and changes in natraemia during hospitalization for acute heart failure and associations with in-hospital and long-term outcomes - from the ESC-HFA EORP Heart Failure Long-Term Registry.
|
Eur J Heart Fail
37114294
|
1 |
18.2 |
2023 |
|
European Society of Cardiology quality indicators for the care and outcomes of adults with pulmonary arterial hypertension. Developed in collaboration with the Heart Failure Association of the European Society of Cardiology.
|
Eur J Heart Fail
36924171
|
1 |
18.2 |
2023 |
|
Prevalence, characteristics and prognostic impact of aortic valve disease in patients with heart failure and reduced, mildly reduced, and preserved ejection fraction: An analysis of the ESC Heart Failure Long-Term Registry.
|
Eur J Heart Fail
37210639
|
0 |
18.2 |
2023 |
|
Heart failure and the heart-brain axis.
|
QJM
37481714
|
1 |
13.3 |
2023 |
|
Anorexia of aging: An international assessment of healthcare providers' knowledge and practice gaps.
|
J Cachexia Sarcopenia Muscle
37897129
|
2 |
8.9 |
2023 |
|
Efficacy of empagliflozin in heart failure with preserved ejection fraction according to frailty status in EMPEROR-Preserved.
|
J Cachexia Sarcopenia Muscle
38158636
|
1 |
8.9 |
2023 |
|
Patient-reported ability to walk 4 m and to wash: New clinical endpoints and predictors of survival in patients with pre-terminal cancer.
|
J Cachexia Sarcopenia Muscle
37222009
|
2 |
8.9 |
2023 |
|
Hand grip strength in patients with advanced cancer: A prospective study.
|
J Cachexia Sarcopenia Muscle
37318103
|
3 |
8.9 |
2023 |
|
The barriers to interprofessional care for cancer cachexia among Japanese healthcare providers: A nationwide survey.
|
J Cachexia Sarcopenia Muscle
38018293
|
2 |
8.9 |
2023 |
|
Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: Update 2023.
|
J Cachexia Sarcopenia Muscle
38148513
|
0 |
8.9 |
2023 |
|
Extent of Abdominal Aortic Calcification Is Associated With Incident Rapid Weight Loss Over 5 Years: The Perth Longitudinal Study of Ageing Women.
|
Arterioscler Thromb Vasc Biol
38095109
|
0 |
8.7 |
2023 |
|
International validation of the Metabolic Exercise test data combined with Cardiac and Kidney Indexes (MECKI) score in heart failure.
|
Eur J Prev Cardiol
37288595
|
1 |
8.3 |
2023 |
|
Comprehensive characterization of non-cardiac comorbidities in acute heart failure: an analysis of ESC-HFA EURObservational Research Programme Heart Failure Long-Term Registry.
|
Eur J Prev Cardiol
37172316
|
2 |
8.3 |
2023 |
|
Natriuretic Peptides: Role in the Diagnosis and Management of Heart Failure: A Scientific Statement From the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society.
|
J Card Fail
37117140
|
4 |
6 |
2023 |
|
Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis.
|
Eur Heart J Cardiovasc Pharmacother
36639130
|
3 |
4.841 |
2023 |
|
Left ventricular ejection fraction digit bias and reclassification of heart failure with mildly reduced vs reduced ejection fraction based on the 2021 definition and classification of heart failure.
|
Am Heart J
37972677
|
0 |
4.8 |
2023 |
|
Cardiac contractility modulation: an effective treatment strategy for heart failure beyond reduced left ventricular ejection fraction?
|
Heart Fail Rev
37198505
|
0 |
4.6 |
2023 |
|
Optimizing outcomes in heart failure: 2022 and beyond.
|
ESC Heart Fail
37060168
|
1 |
3.8 |
2023 |
|
Effects of Sacubitril/Valsartan on Exercise Capacity in Patients with Heart Failure with Reduced Ejection Fraction and the Role of Percentage of Delayed Enhancement Measured by Cardiac Magnetic Resonance in Predicting Therapeutic Response: A Multicentre Study.
|
Card Fail Rev
37427008
|
1 |
2.5 |
2023 |
|
Prognostic utility of serum NT-proBNP (fragments 1-76aa and 13-71aa) and galectin-3 in predicting death and re-hospitalisation due to cardiovascular events in patients with heart failure.
|
Heart Vessels
37537380
|
1 |
1.5 |
2023 |
|
[2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension].
|
G Ital Cardiol (Rome)
36995376
|
4 |
0.415 |
2023 |
|
An update on global epidemiology in heart failure.
|
Eur Heart J
35578978
|
8 |
39.3 |
2022 |
|
Heart Failure Association/European Society of Cardiology Atlas second edition: new insights into understanding the burden of heart failure.
|
Eur Heart J
36201512
|
1 |
39.3 |
2022 |
|
Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial.
|
Eur Heart J
35900838
|
20 |
39.3 |
2022 |
|
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.
|
Eur Heart J
36017548
|
347 |
39.3 |
2022 |
|
Data standards for heart failure: the European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart).
|
Eur Heart J
35443059
|
0 |
39.3 |
2022 |
|
What's all the fuss about a new guideline?
|
Eur J Heart Fail
35442540
|
0 |
18.2 |
2022 |
|
Sodium-glucose co-transporter 2 inhibitors as an early, first-line therapy in patients with heart failure and reduced ejection fraction.
|
Eur J Heart Fail
34894038
|
18 |
18.2 |
2022 |
|
Cardiac remodelling - Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology.
|
Eur J Heart Fail
35334137
|
7 |
18.2 |
2022 |
|
Figures of the Heart Failure Association: Professor Finn Gustafsson, Board Member, 2020-2022.
|
Eur J Heart Fail
35417084
|
0 |
18.2 |
2022 |
|
A comprehensive characterization of acute heart failure with preserved versus mildly reduced versus reduced ejection fraction - insights from the ESC-HFA EORP Heart Failure Long-Term Registry.
|
Eur J Heart Fail
34962044
|
11 |
18.2 |
2022 |
|
Myocarditis following COVID-19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC) and the ESC Working Group on Myocardial and Pericardial Diseases.
|
Eur J Heart Fail
36065751
|
18 |
18.2 |
2022 |
|
Education and certification on heart failure of the Heart Failure Association of the European Society of Cardiology.
|
Eur J Heart Fail
35014132
|
0 |
18.2 |
2022 |
|
Baroreflex activation therapy with the Barostim™ device in patients with heart failure with reduced ejection fraction: a patient level meta-analysis of randomized controlled trials.
|
Eur J Heart Fail
35713888
|
5 |
18.2 |
2022 |
|
Figures of the Heart Failure Association: Doctor Amina Rakisheva, Board Member, 2020-2022.
|
Eur J Heart Fail
35415960
|
0 |
18.2 |
2022 |
|
Biomarkers for the prediction of heart failure and cardiovascular events in patients with type 2 diabetes: a position statement from the Heart Failure Association of the European Society of Cardiology.
|
Eur J Heart Fail
35703329
|
4 |
18.2 |
2022 |
|
Prevention of sudden death in heart failure with reduced ejection fraction: do we still need an implantable cardioverter-defibrillator for primary prevention?
|
Eur J Heart Fail
35753058
|
5 |
18.2 |
2022 |
|
Targeted therapies in genetic dilated and hypertrophic cardiomyopathies: from molecular mechanisms to therapeutic targets. A position paper from the Heart Failure Association (HFA) and the Working Group on Myocardial Function of the European Society of Cardiology (ESC).
|
Eur J Heart Fail
34969177
|
9 |
18.2 |
2022 |
|
Congestion in heart failure: a circulating biomarker-based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology.
|
Eur J Heart Fail
36039656
|
12 |
18.2 |
2022 |
|
Weight change and clinical outcomes in heart failure with reduced ejection fraction: insights from EMPEROR-Reduced.
|
Eur J Heart Fail
36325584
|
4 |
18.2 |
2022 |
|
Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology.
|
Eur J Heart Fail
35488811
|
6 |
18.2 |
2022 |
|
Biomarkers in heart failure clinical trials. A review from the Biomarkers Working Group of the Heart Failure Association of the European Society of Cardiology.
|
Eur J Heart Fail
36073112
|
6 |
18.2 |
2022 |
|
Exercise testing in heart failure with preserved ejection fraction: an appraisal through diagnosis, pathophysiology and therapy - A clinical consensus statement of the Heart Failure Association and European Association of Preventive Cardiology of the European Society of Cardiology.
|
Eur J Heart Fail
35775383
|
6 |
18.2 |
2022 |
|
Head-to-head comparison between recommendations by the ESC and ACC/AHA/HFSA heart failure guidelines.
|
Eur J Heart Fail
35579428
|
2 |
18.2 |
2022 |
|
Responder analysis for improvement in 6-min walk test with ferric carboxymaltose in patients with heart failure with reduced ejection fraction and iron deficiency.
|
Eur J Heart Fail
35334136
|
3 |
18.2 |
2022 |
|
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC.
|
Eur J Heart Fail
35083827
|
213 |
18.2 |
2022 |
|
Health status improvement with ferric carboxymaltose in heart failure with reduced ejection fraction and iron deficiency.
|
Eur J Heart Fail
35279929
|
3 |
18.2 |
2022 |
|
European Society of Cardiology quality indicators for the care and outcomes of adults with heart failure. Developed by the Working Group for Heart Failure Quality Indicators in collaboration with the Heart Failure Association of the European Society of Cardiology.
|
Eur J Heart Fail
35083826
|
7 |
18.2 |
2022 |
|
An international Delphi consensus regarding best practice recommendations for hyperkalaemia across the cardiorenal spectrum.
|
Eur J Heart Fail
35791065
|
4 |
18.2 |
2022 |
|
Renal effects of guideline-directed medical therapies in heart failure: a consensus document from the Heart Failure Association of the European Society of Cardiology.
|
Eur J Heart Fail
35239201
|
12 |
18.2 |
2022 |
|
Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology.
|
Eur J Heart Fail
35083829
|
12 |
18.2 |
2022 |
|
Consensus statement on the current pharmacological prevention and management of heart failure.
|
Med J Aust
35908234
|
3 |
11.4 |
2022 |
|
Global burden of heart failure: a comprehensive and updated review of epidemiology.
|
Cardiovasc Res
35150240
|
182 |
10.8 |
2022 |
|
The atypical β-blocker S-oxprenolol reduces cachexia and improves survival in a rat cancer cachexia model.
|
J Cachexia Sarcopenia Muscle
36346141
|
3 |
8.9 |
2022 |
|
Long-term indoor gunshot exposure of special police forces induces bronchitic reactions and elevated blood lead levels-The Berlin shooting range study.
|
J Cachexia Sarcopenia Muscle
36539958
|
3 |
8.9 |
2022 |
|
Identification and management of cancer cachexia in patients: Assessment of healthcare providers' knowledge and practice gaps.
|
J Cachexia Sarcopenia Muscle
36218155
|
6 |
8.9 |
2022 |
|
Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology.
|
Eur J Prev Cardiol
35083485
|
2 |
8.3 |
2022 |
|
Corrigendum to: 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: Developed by the Task Force on cardiac pacing and cardiac resynchronization therapy of the European Society of Cardiology (ESC): With the special contribution of the European Heart Rhythm Association (EHRA).
|
Europace
35253863
|
11 |
6.1 |
2022 |
|
2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy.
|
Europace
34455427
|
36 |
6.1 |
2022 |
|
Minimal Clinically Important Differences in 6-Minute Walk Test in Patients With HFrEF and Iron Deficiency.
|
J Card Fail
36332897
|
1 |
6 |
2022 |
|
Potentially inappropriate prescriptions in heart failure with reduced ejection fraction: ESC position statement on heart failure with reduced ejection fraction-specific inappropriate prescribing.
|
Eur Heart J Cardiovasc Pharmacother
32941594
|
5 |
4.841 |
2022 |
|
Dutogliptin in Combination with Filgrastim in Early Recovery Post-Myocardial Infarction-The REC-DUT-002 Trial.
|
J Clin Med
36233596
|
0 |
3.9 |
2022 |
|
Impact analysis of heart failure across European countries: an ESC-HFA position paper.
|
ESC Heart Fail
35869679
|
6 |
3.8 |
2022 |
|
Robustness of outcomes in trials evaluating sodium-glucose co-transporter 2 inhibitors for heart failure.
|
ESC Heart Fail
35029056
|
1 |
3.8 |
2022 |
|
Medical Treatment of Heart Failure with Reduced Ejection Fraction in the Elderly.
|
Card Fail Rev
35601008
|
0 |
2.5 |
2022 |
|
Clinical and economic impact of ferric carboxymaltose treatment for iron deficiency in patients stabilized following acute heart failure: a multinational study.
|
J Med Econ
36476095
|
1 |
2.4 |
2022 |
|
Feasibility of the cardiac output response to stress test in suspected heart failure patients.
|
Fam Pract
35083480
|
0 |
2.2 |
2022 |
|
The four pillars of HFrEF therapy: is it time to treat heart failure regardless of ejection fraction?
|
Eur Heart J Suppl
36545228
|
2 |
1.6 |
2022 |
|
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC.
|
G Ital Cardiol (Rome)
35373785
|
3 |
0.415 |
2022 |
|
[2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy Developed by the Task Force on cardiac pacing and cardiac resynchronization therapy of the European Society of Cardiology (ESC) With the special contribution of the European Heart Rhythm Association (EHRA)].
|
G Ital Cardiol (Rome)
35771031
|
1 |
0.415 |
2022 |
|
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC.
|
Rev Esp Cardiol (Engl Ed)
35636830
|
27 |
0.385 |
2022 |
|
2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: Developed by the Task Force on cardiac pacing and cardiac resynchronization therapy of the European Society of Cardiology (ESC) With the special contribution of the European Heart Rhythm Association (EHRA).
|
Rev Esp Cardiol (Engl Ed)
35525571
|
6 |
0.385 |
2022 |
|
Redefining β-blocker response in heart failure patients with sinus rhythm and atrial fibrillation: a machine learning cluster analysis.
|
Lancet
34474011
|
18 |
202.731 |
2021 |
|
Exercise for Frail, Elderly Patients with Acute Heart Failure - A Strong Step Forward.
|
N Engl J Med
33999546
|
0 |
176.079 |
2021 |
|
Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes.
|
N Engl J Med
34449181
|
215 |
176.079 |
2021 |
|
'Peptide for Life' in primary care: work in progress.
|
Eur Heart J
34897424
|
2 |
35.855 |
2021 |
|
ESC/HFA Quality of Care Centres: the ultimate frontier in unifying heart failure management.
|
Eur Heart J
34718508
|
1 |
35.855 |
2021 |
|
Atrial disease and heart failure: the common soil hypothesis proposed by the Heart Failure Association of the European Society of Cardiology.
|
Eur Heart J
34875053
|
6 |
35.855 |
2021 |
|
Cardiac events associated with immune checkpoint inhibitor therapy: the devil is in the detail.
|
Eur Heart J
33611381
|
1 |
35.855 |
2021 |
|
Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC.
|
Eur Heart J
34649282
|
102 |
35.855 |
2021 |
|
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.
|
Eur Heart J
34447992
|
2045 |
35.855 |
2021 |
|
The management of secondary mitral regurgitation in patients with heart failure: a joint position statement from the Heart Failure Association (HFA), European Association of Cardiovascular Imaging (EACVI), European Heart Rhythm Association (EHRA), and European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC.
|
Eur Heart J
33734354
|
19 |
35.855 |
2021 |
|
2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy.
|
Eur Heart J
34455430
|
263 |
35.855 |
2021 |
|
Patiromer for the management of hyperkalaemia in patients receiving renin-angiotensin-aldosterone system inhibitors for heart failure: design and rationale of the DIAMOND trial.
|
Eur J Heart Fail
34800079
|
10 |
18.2 |
2021 |
|
Best of European Journal of Heart Failure at the ESC/HFA Heart Failure Congress 2021.
|
Eur J Heart Fail
34263508
|
0 |
17.349 |
2021 |
|
Figures of the Heart Failure Association: Professor Dr. Wilfried Mullens, Board Member, 2018-2022, Coordinator of the Study Group on Cardiorenal Dysfunction and the Committee on Cardiac Devices, Deputy on Certification of the Committee on Education.
|
Eur J Heart Fail
34369636
|
0 |
17.349 |
2021 |
|
Integration of imaging and circulating biomarkers in heart failure: a consensus document by the Biomarkers and Imaging Study Groups of the Heart Failure Association of the European Society of Cardiology.
|
Eur J Heart Fail
34482622
|
6 |
17.349 |
2021 |
|
The Heart Failure Association Atlas: Heart Failure Epidemiology and Management Statistics 2019.
|
Eur J Heart Fail
33634931
|
42 |
17.349 |
2021 |
|
Feasibility and efficacy of transcatheter interatrial shunt devices for chronic heart failure: a systematic review and meta-analysis.
|
Eur J Heart Fail
34628706
|
4 |
17.349 |
2021 |
|
The ever-changing field of mechanical circulatory support: new challenges at the advent of the 'single device era'.
|
Eur J Heart Fail
34296495
|
2 |
17.349 |
2021 |
|
Heart Failure Association of the ESC, Heart Failure Society of America and Japanese Heart Failure Society Position statement on endomyocardial biopsy.
|
Eur J Heart Fail
34010472
|
40 |
17.349 |
2021 |
|
Circulating heart failure biomarkers beyond natriuretic peptides: review from the Biomarker Study Group of the Heart Failure Association (HFA), European Society of Cardiology (ESC).
|
Eur J Heart Fail
34498368
|
17 |
17.349 |
2021 |
|
Advanced cancer is also a heart failure syndrome: a hypothesis.
|
Eur J Heart Fail
33247608
|
10 |
17.349 |
2021 |
|
Treatments delayed lead to lives lost.
|
Eur J Heart Fail
33686776
|
0 |
17.349 |
2021 |
|
National Heart Failure Societies Summit 2020.
|
Eur J Heart Fail
33749046
|
0 |
17.349 |
2021 |
|
The ergoreflex: how the skeletal muscle modulates ventilation and cardiovascular function in health and disease.
|
Eur J Heart Fail
34268843
|
8 |
17.349 |
2021 |
|
Navigating between Scylla and Charybdis: challenges and strategies for implementing guideline-directed medical therapy in heart failure with reduced ejection fraction.
|
Eur J Heart Fail
34755422
|
5 |
17.349 |
2021 |
|
The Heart Failure Association further develops it educational engagement working together on a Masters of Science in heart failure with St George's Hospital in London.
|
Eur J Heart Fail
34355853
|
0 |
17.349 |
2021 |
|
Heart failure drug titration, discontinuation, mortality and heart failure hospitalization risk: a multinational observational study (US, UK and Sweden).
|
Eur J Heart Fail
34132001
|
24 |
17.349 |
2021 |
|
Ferric carboxymaltose for the treatment of iron deficiency in heart failure: a multinational cost-effectiveness analysis utilising AFFIRM-AHF.
|
Eur J Heart Fail
34191394
|
6 |
17.349 |
2021 |
|
The 'Peptide for Life' Initiative: a call for action to provide equal access to the use of natriuretic peptides in the diagnosis of acute heart failure across Europe.
|
Eur J Heart Fail
34231321
|
2 |
17.349 |
2021 |
|
Sodium-glucose co-transporter 2 inhibitors in heart failure with preserved ejection fraction: reasons for optimism.
|
Eur J Heart Fail
34173305
|
5 |
17.349 |
2021 |
|
Risk stratification and management of women with cardiomyopathy/heart failure planning pregnancy or presenting during/after pregnancy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy.
|
Eur J Heart Fail
33609068
|
8 |
17.349 |
2021 |
|
Why we love heart failure: an introduction to the universal definition of heart failure.
|
Eur J Heart Fail
33773017
|
0 |
17.349 |
2021 |
|
COVID-19 vaccination in patients with heart failure: a position paper of the Heart Failure Association of the European Society of Cardiology.
|
Eur J Heart Fail
34612556
|
18 |
17.349 |
2021 |
|
The Altmetric Attention Score: how science tries to meet social media.
|
Eur J Heart Fail
33609070
|
1 |
17.349 |
2021 |
|
Patient profiling in heart failure for tailoring medical therapy. A consensus document of the Heart Failure Association of the European Society of Cardiology.
|
Eur J Heart Fail
33932268
|
48 |
17.349 |
2021 |
|
Ventricular tachycardia, premature ventricular contractions, and mortality in unselected patients with lung, colon, or pancreatic cancer: a prospective study.
|
Eur J Heart Fail
33222388
|
10 |
17.349 |
2021 |
|
Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: Endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association.
|
Eur J Heart Fail
33605000
|
211 |
17.349 |
2021 |
|
Guidance on the management of left ventricular assist device (LVAD) supported patients for the non-LVAD specialist healthcare provider: executive summary.
|
Eur J Heart Fail
34409711
|
5 |
17.349 |
2021 |
|
Figures of the Heart Failure Association: Loreena Hill (HFA Board Member and Nurse Representative 2016-2020, and HFA Secretary 2020-2022).
|
Eur J Heart Fail
34357665
|
0 |
17.349 |
2021 |
|
Percutaneous Mitral Valve Annuloplasty in Patients With Secondary Mitral Regurgitation and Severe Left Ventricular Enlargement.
|
JACC Heart Fail
33992567
|
2 |
12.544 |
2021 |
|
Advanced cancer is also a heart failure syndrome: a hypothesis.
|
J Cachexia Sarcopenia Muscle
33734609
|
7 |
12.063 |
2021 |
|
Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2021.
|
J Cachexia Sarcopenia Muscle
34904399
|
176 |
12.063 |
2021 |
|
Drug Treatment of Heart Failure with Reduced Ejection Fraction: Defining the Role of Vericiguat.
|
Drugs
34478114
|
1 |
11.431 |
2021 |
|
Combined aerobic/resistance/inspiratory muscle training as the 'optimum' exercise programme for patients with chronic heart failure: ARISTOS-HF randomized clinical trial.
|
Eur J Prev Cardiol
33624071
|
4 |
8.526 |
2021 |
|
Serum uric acid and outcomes in patients with chronic heart failure through the whole spectrum of ejection fraction phenotypes: Analysis of the ESC-EORP Heart Failure Long-Term (HF LT) Registry.
|
Eur J Intern Med
33896684
|
10 |
7.749 |
2021 |
|
Pathophysiological Basis for Nutraceutical Supplementation in Heart Failure: A Comprehensive Review.
|
Nutrients
33477388
|
13 |
6.706 |
2021 |
|
Universal Definition and Classification of Heart Failure: A Report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure.
|
J Card Fail
33663906
|
114 |
6.592 |
2021 |
|
Universal Definition and Classification of Heart Failure.
|
J Card Fail
33662581
|
24 |
6.592 |
2021 |
|
Heart Failure Association, Heart Failure Society of America, and Japanese Heart Failure Society Position Statement on Endomyocardial Biopsy.
|
J Card Fail
34022400
|
9 |
6.592 |
2021 |
|
Spontaneous Non-Sustained Ventricular Tachycardia and Premature Ventricular Contractions and Their Prognostic Relevance in Patients with Cancer in Routine Care.
|
Cancers (Basel)
34065780
|
4 |
6.575 |
2021 |
|
Withdrawn as duplicate: Optimized Implementation of cardiac resynchronization therapy - a call for action for referral and optimization of care.
|
Europace
33544835
|
0 |
5.486 |
2021 |
|
Optimized implementation of cardiac resynchronization therapy: a call for action for referral and optimization of care.
|
Europace
34037728
|
7 |
5.486 |
2021 |
|
Sarcopenia and cachexia in chronic diseases: from mechanisms to treatment.
|
Pol Arch Intern Med
34775741
|
1 |
5.218 |
2021 |
|
New trial evidence and guidelines on heart failure: news from the European Society of Cardiology Congress 2021.
|
Eur Heart J Cardiovasc Pharmacother
34529057
|
0 |
4.841 |
2021 |
|
Functional outcomes with Carillon device over 1 year in patients with functional mitral regurgitation of Grades 2+ to 4+: results from the REDUCE-FMR trial.
|
ESC Heart Fail
33619896
|
2 |
3.612 |
2021 |
|
HFA of the ESC Position paper on the management of LVAD supported patients for the non LVAD specialist healthcare provider Part 1: Introduction and at the non-hospital settings in the community.
|
ESC Heart Fail
34519177
|
4 |
3.612 |
2021 |
|
'Time is prognosis' in heart failure: time-to-treatment initiation as a modifiable risk factor.
|
ESC Heart Fail
34655282
|
18 |
3.612 |
2021 |
|
HFA of the ESC position paper on the management of LVAD-supported patients for the non-LVAD specialist healthcare provider Part 3: at the hospital and discharge.
|
ESC Heart Fail
34585525
|
4 |
3.612 |
2021 |
|
A year in heart failure: an update of recent findings.
|
ESC Heart Fail
34918477
|
6 |
3.612 |
2021 |
|
Heart Failure Association of the European Society of Cardiology position paper on the management of left ventricular assist device-supported patients for the non-left ventricular assist device specialist healthcare provider: Part 2: at the emergency department.
|
ESC Heart Fail
34523254
|
4 |
3.612 |
2021 |
|
Expect the Unexpected in the Medical Treatment of Heart Failure with Reduced Ejection Fraction: between Scientific Evidence and Clinical Wisdom.
|
Int J Heart Fail
36262556
|
1 |
0 |
2021 |
|
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD.
|
Eur Heart J
31497854
|
1086 |
29.983 |
2020 |
|
Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).
|
Eur Heart J
32498081
|
36 |
29.983 |
2020 |
|
Exergaming for heart failure: an idea so good it just ought to work.
|
Eur J Heart Fail
32391941
|
1 |
17.349 |
2020 |
|
Self-care of heart failure patients: practical management recommendations from the Heart Failure Association of the European Society of Cardiology.
|
Eur J Heart Fail
32945600
|
58 |
17.349 |
2020 |
|
Measuring physical activity with activity monitors in patients with heart failure: from literature to practice. A position paper from the Committee on Exercise Physiology and Training of the Heart Failure Association of the European Society of Cardiology.
|
Eur J Heart Fail
33111464
|
7 |
17.349 |
2020 |
|
Do Cheyne and Stokes have an important message for modern-day patients with heart failure? Yes, they do.
|
Eur J Heart Fail
32469126
|
0 |
17.349 |
2020 |
|
Heart Failure Association of the European Society of Cardiology update on sodium-glucose co-transporter 2 inhibitors in heart failure.
|
Eur J Heart Fail
33068051
|
21 |
15.534 |
2020 |
|
The European Society of Cardiology Heart Failure Association Study Group on Peripartum Cardiomyopathy - what has been achieved in 10 years.
|
Eur J Heart Fail
32452103
|
1 |
15.534 |
2020 |
|
Sodium-glucose co-transporter 2 inhibitors in heart failure: beyond glycaemic control. A position paper of the Heart Failure Association of the European Society of Cardiology.
|
Eur J Heart Fail
32618086
|
36 |
15.534 |
2020 |
|
Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society.
|
Eur J Heart Fail
32463967
|
142 |
15.534 |
2020 |
|
Learning together: insights from the first Heart Failure Association patient forum.
|
Eur J Heart Fail
32964605
|
0 |
15.534 |
2020 |
|
Management of heart failure patients with COVID-19: a joint position paper of the Chinese Heart Failure Association & National Heart Failure Committee and the Heart Failure Association of the European Society of Cardiology.
|
Eur J Heart Fail
32463543
|
54 |
15.534 |
2020 |
|
Acute coronary syndromes and acute heart failure: a diagnostic dilemma and high-risk combination. A statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology.
|
Eur J Heart Fail
32347648
|
19 |
15.534 |
2020 |
|
The Heart Failure Association Atlas: rationale, objectives, and methods.
|
Eur J Heart Fail
32125085
|
9 |
15.534 |
2020 |
|
Epidemiology, pathophysiology and contemporary management of cardiogenic shock - a position statement from the Heart Failure Association of the European Society of Cardiology.
|
Eur J Heart Fail
32469155
|
76 |
15.534 |
2020 |
|
Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry.
|
Eur J Heart Fail
32243669
|
26 |
15.534 |
2020 |
|
Pulmonary artery pressure monitoring, a reality for Europe?
|
Eur J Heart Fail
32892483
|
0 |
15.534 |
2020 |
|
Figures of the Heart Failure Association: Prof. Lars H. Lund, Chair of the HFA Committee on Registries, Surveys and Epidemiology and HFA Board Member (from 2016).
|
Eur J Heart Fail
32964522
|
0 |
15.534 |
2020 |
|
Figures of the Heart Failure Association (HFA): Dr. Rudolf de Boer, HFA Board Member (2014-2020), Chair of the Basic Science Section (2016-2018), coordinator of the Study Group on Heart Failure with Preserved Ejection Fraction, and member of the HFA study groups of Translational Research and Cardio-oncology.
|
Eur J Heart Fail
32128968
|
0 |
15.534 |
2020 |
|
Optimized implementation of cardiac resynchronization therapy: a call for action for referral and optimization of care: A joint position statement from the Heart Failure Association (HFA), European Heart Rhythm Association (EHRA), and European Association of Cardiovascular Imaging (EACVI) of the European Society of Cardiology.
|
Eur J Heart Fail
33136300
|
33 |
15.534 |
2020 |
|
Prevalence of risk of thrombosis and of bleeding and antithrombotic treatment in patients with heart failure.
|
Eur J Heart Fail
32232914
|
2 |
15.534 |
2020 |
|
Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry.
|
Eur J Heart Fail
32237110
|
11 |
15.534 |
2020 |
|
Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).
|
Eur J Heart Fail
33094495
|
37 |
15.534 |
2020 |
|
Vericiguat for heart failure and the VICTORIA trial - the dog that didn't bark?
|
Eur J Heart Fail
32115834
|
2 |
15.534 |
2020 |
|
Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of Cardiology.
|
Eur J Heart Fail
33006257
|
78 |
15.534 |
2020 |
|
Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC).
|
Eur J Heart Fail
32621569
|
94 |
15.534 |
2020 |
|
Evaluation of kidney function throughout the heart failure trajectory - a position statement from the Heart Failure Association of the European Society of Cardiology.
|
Eur J Heart Fail
31908120
|
76 |
15.534 |
2020 |
|
Integration of a palliative approach into heart failure care: a European Society of Cardiology Heart Failure Association position paper.
|
Eur J Heart Fail
32892431
|
36 |
15.534 |
2020 |
|
Heart Failure Association of the European Society of Cardiology Quality of Care Centres Programme: design and accreditation document.
|
Eur J Heart Fail
32187429
|
5 |
15.534 |
2020 |
|
The 10th year of the Journal of Cachexia, Sarcopenia and Muscle.
|
J Cachexia Sarcopenia Muscle
33340288
|
1 |
12.91 |
2020 |
|
Nutrition in the spotlight in cachexia, sarcopenia and muscle: avoiding the wildfire.
|
J Cachexia Sarcopenia Muscle
33382196
|
19 |
12.063 |
2020 |
|
Weight loss, malnutrition, and cachexia in COVID-19: facts and numbers.
|
J Cachexia Sarcopenia Muscle
33382211
|
54 |
12.063 |
2020 |
|
Future developments in the MECKI score initiative.
|
Eur J Prev Cardiol
33238739
|
0 |
7.804 |
2020 |
|
Six-minute walk test: prognostic value and effects of nebivolol versus placebo in elderly patients with heart failure from the SENIORS trial.
|
Clin Res Cardiol
33136223
|
1 |
6.138 |
2020 |
|
Individual patient data meta-analysis of the effects of the CARILLON® mitral contour system.
|
ESC Heart Fail
34351074
|
4 |
4.411 |
2020 |
|
Heart failure in the last year: progress and perspective.
|
ESC Heart Fail
33277825
|
23 |
4.411 |
2020 |
|
The heart failure specialists of tomorrow: a network for young cardiovascular scientists and clinicians.
|
ESC Heart Fail
32352242
|
1 |
4.411 |
2020 |
|
Is heart failure misdiagnosed in hospitalized patients with preserved ejection fraction? From the European Society of Cardiology - Heart Failure Association EURObservational Research Programme Heart Failure Long-Term Registry.
|
ESC Heart Fail
32618139
|
12 |
4.411 |
2020 |
|
Efficacy and safety of SGLT2 inhibitors in heart failure: systematic review and meta-analysis.
|
ESC Heart Fail
33586910
|
28 |
4.411 |
2020 |
|
Targeting breathlessness in heart failure.
|
ESC Heart Fail
31916383
|
1 |
3.902 |
2020 |
|
An expert opinion paper on statin adherence and implementation of new lipid-lowering medications by the ESC Working Group on Cardiovascular Pharmacotherapy: Barriers to be overcome.
|
Eur Heart J Cardiovasc Pharmacother
31873726
|
17 |
2.92 |
2020 |
|
Beta-blockers, hypertension, and weight gain: the farmer, the chicken, and the egg.
|
Hong Kong Med J
32077860
|
1 |
2.227 |
2020 |
|
Impact of Renal Impairment on Beta-Blocker Efficacy in Patients With Heart Failure.
|
J Am Coll Cardiol
31806133
|
15 |
20.589 |
2019 |
|
Impact of Exercise Rehabilitation on Exercise Capacity and Quality-of-Life in Heart Failure: Individual Participant Meta-Analysis.
|
J Am Coll Cardiol
30922474
|
60 |
20.589 |
2019 |
|
Drug dosing for heart failure: does sex or size matter?
|
Nat Rev Cardiol
31628437
|
0 |
20.26 |
2019 |
|
Heart Failure Association position papers - a new way to advance the field.
|
Eur J Heart Fail
31840361
|
0 |
15.534 |
2019 |
|
Figures of the Heart Failure Association (HFA): Prof. Dr. Tiny Jaarsma, HFA Board Member (2018-2020), Coordinator Patient Care: Management and Delivery Committee and Co-Chair HFA Task Force on Palliative Care.
|
Eur J Heart Fail
31886944
|
0 |
15.534 |
2019 |
|
Sex- and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long-Term Registry.
|
Eur J Heart Fail
31863522
|
24 |
15.534 |
2019 |
|
European Society of Cardiology/Heart Failure Association position paper on the role and safety of new glucose-lowering drugs in patients with heart failure.
|
Eur J Heart Fail
31816162
|
38 |
15.534 |
2019 |
|
The first heart failure meeting in the Republic of Kazakhstan.
|
Eur J Heart Fail
31069911
|
0 |
11.627 |
2019 |
|
When is an implantable cardioverter-defibrillator controversial?
|
Eur J Heart Fail
31414559
|
0 |
11.627 |
2019 |
|
Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology.
|
Eur J Heart Fail
31129923
|
191 |
11.627 |
2019 |
|
Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology.
|
Eur J Heart Fail
30989768
|
94 |
11.627 |
2019 |
|
Regional differences in exercise training implementation in heart failure: findings from the Exercise Training in Heart Failure (ExTraHF) survey.
|
Eur J Heart Fail
31343108
|
2 |
11.627 |
2019 |
|
Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world.
|
Eur J Heart Fail
31132222
|
15 |
11.627 |
2019 |
|
Acute heart failure congestion and perfusion status - impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry.
|
Eur J Heart Fail
31127678
|
62 |
11.627 |
2019 |
|
Heart Failure Association/European Society of Cardiology position paper on frailty in patients with heart failure.
|
Eur J Heart Fail
31646718
|
66 |
11.627 |
2019 |
|
Activities of the study groups - the Study Group on Takotsubo Syndrome.
|
Eur J Heart Fail
31414523
|
0 |
11.627 |
2019 |
|
Heart Failure Atlas, a major project of the Heart Failure Association in concert with the European Society of Cardiology.
|
Eur J Heart Fail
30969474
|
0 |
11.627 |
2019 |
|
Figures of the Heart Failure Association (HFA): Prof. Dr. Jelena Čelutkienė, HFA Board Member (2016-2020) and co-coordinator of the Imaging Study Group of the HFA Diagnosis Committee.
|
Eur J Heart Fail
31833202
|
0 |
11.627 |
2019 |
|
Figures of the Heart Failure Association (HFA): Prof. Dr. med. Thomas Thum, Chair of the ESC Working Group on Myocardial Function and ex-officio HFA Board Member (2018-2020).
|
Eur J Heart Fail
31410951
|
0 |
11.627 |
2019 |
|
Figures of the Heart Failure Association: Dr. Ovidiu Chioncel, HFA Board Member, 2018-2020.
|
Eur J Heart Fail
31389148
|
0 |
11.627 |
2019 |
|
Figures of the Heart Failure Association: Professor Dr. med. Johann Bauersachs, Chair of the Clinical Science Section.
|
Eur J Heart Fail
31069912
|
0 |
11.627 |
2019 |
|
News from the American Heart Association: more on sodium-glucose co-transporter 2 inhibitors, diabetes and heart failure.
|
Eur J Heart Fail
30884001
|
0 |
11.627 |
2019 |
|
The use of diuretics in heart failure with congestion - a position statement from the Heart Failure Association of the European Society of Cardiology.
|
Eur J Heart Fail
30600580
|
203 |
11.627 |
2019 |
|
Figures of the Heart Failure Association: Petar M. Seferović, President, 2018-2020.
|
Eur J Heart Fail
30883997
|
0 |
11.627 |
2019 |
|
HFA Committee on Comorbidities - report of a meeting on physiological monitoring in the complex multi-morbid heart failure patient.
|
Eur J Heart Fail
31069910
|
2 |
11.627 |
2019 |
|
Expert consensus document: Reporting checklist for quantification of pulmonary congestion by lung ultrasound in heart failure.
|
Eur J Heart Fail
31218825
|
35 |
11.627 |
2019 |
|
Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations.
|
Eur J Heart Fail
31222929
|
152 |
11.627 |
2019 |
|
GLIM criteria for the diagnosis of malnutrition - A consensus report from the global clinical nutrition community.
|
J Cachexia Sarcopenia Muscle
30920778
|
193 |
9.802 |
2019 |
|
Orphan disease status of cancer cachexia in the USA and in the European Union: a systematic review.
|
J Cachexia Sarcopenia Muscle
30920776
|
59 |
9.802 |
2019 |
|
The Journal of Cachexia, Sarcopenia and Muscle stays the front-runner in geriatrics and gerontology.
|
J Cachexia Sarcopenia Muscle
31821753
|
1 |
9.802 |
2019 |
|
Sarcopenia: A Time for Action. An SCWD Position Paper.
|
J Cachexia Sarcopenia Muscle
31523937
|
174 |
9.802 |
2019 |
|
Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2019.
|
J Cachexia Sarcopenia Muscle
31661195
|
306 |
9.802 |
2019 |
|
Exercise-based cardiac rehabilitation for adults with heart failure.
|
Cochrane Database Syst Rev
30695817
|
150 |
7.89 |
2019 |
|
Is left atrium the best kept secret of the heart? Left atrial dilatation and cardiovascular outcomes.
|
Heart
31471465
|
5 |
5.213 |
2019 |
|
New horizons in management of heart failure in older patients.
|
Age Ageing
31697342
|
2 |
4.902 |
2019 |
|
Management of asymptomatic arrhythmias: a European Heart Rhythm Association (EHRA) consensus document, endorsed by the Heart Failure Association (HFA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin America Heart Rhythm Society (LAHRS).
|
Europace
30882141
|
26 |
4.045 |
2019 |
|
Brachial pulse pressure in acute heart failure. Results of the Heart Failure Registry.
|
ESC Heart Fail
31814303
|
2 |
3.902 |
2019 |
|
Recent advances in cardio-oncology: a report from the 'Heart Failure Association 2019 and World Congress on Acute Heart Failure 2019'.
|
ESC Heart Fail
31884717
|
16 |
3.902 |
2019 |
|
Ageing, demographics, and heart failure.
|
Eur Heart J Suppl
31885504
|
10 |
1.655 |
2019 |
|
Implantable devices for heart failure monitoring: the CardioMEMS™ system.
|
Eur Heart J Suppl
31908617
|
2 |
1.655 |
2019 |
|
Heart failure in dilated non-ischaemic cardiomyopathy.
|
Eur Heart J Suppl
31908615
|
9 |
1.655 |
2019 |
|
Monitoring for sleep-disordered breathing in heart failure.
|
Eur Heart J Suppl
31908614
|
2 |
1.655 |
2019 |
|
Heart failure management of the elderly patient: focus on frailty, sarcopaenia, cachexia, and dementia: conclusions.
|
Eur Heart J Suppl
31885512
|
2 |
1.655 |
2019 |
|
Physiological monitoring in the complex multimorbid heart failure patient - Conclusions.
|
Eur Heart J Suppl
31908622
|
2 |
1.655 |
2019 |
|
Renal function, electrolytes, and congestion monitoring in heart failure.
|
Eur Heart J Suppl
31908612
|
4 |
1.655 |
2019 |
|
Left ventricular function monitoring in heart failure.
|
Eur Heart J Suppl
31908610
|
2 |
1.655 |
2019 |
|
Heart rate and blood pressure monitoring in heart failure.
|
Eur Heart J Suppl
31908609
|
3 |
1.655 |
2019 |
|
Monitoring of biomarkers in heart failure.
|
Eur Heart J Suppl
31908607
|
12 |
1.655 |
2019 |
|
Cardiac cachexia: the mandate to increase clinician awareness.
|
Curr Opin Support Palliat Care
31469664
|
6 |
1.618 |
2019 |
|
Erratum to: Foreword.
|
Card Fail Rev
30847248
|
0 |
0 |
2019 |
|
Foreword.
|
Card Fail Rev
30847237
|
0 |
0 |
2019 |
|
Foreword.
|
Card Fail Rev
31768267
|
0 |
0 |
2019 |
|
Foreword.
|
Card Fail Rev
31179013
|
0 |
0 |
2019 |
|
CardioScape mapping the cardiovascular funding landscape in Europe.
|
Eur Heart J
28449050
|
2 |
23.239 |
2018 |
|
Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials.
|
Eur Heart J
29040525
|
166 |
23.239 |
2018 |
|
Prognostic implications of atrial fibrillation in heart failure with reduced, mid-range, and preserved ejection fraction: a report from 14 964 patients in the European Society of Cardiology Heart Failure Long-Term Registry.
|
Eur Heart J
30325423
|
77 |
23.239 |
2018 |
|
Corrigendum to 'Role of cardiopulmonary exercise testing in clinical stratification in heart failure. A position paper from the Committee on Exercise Physiology and Training of the Heart Failure Association of the European Society of Cardiology' [Eur J Heart Fail 2018;20:3-15].
|
Eur J Heart Fail
30303623
|
2 |
13.965 |
2018 |
|
Cancer diagnosis in patients with heart failure: epidemiology, clinical implications and gaps in knowledge.
|
Eur J Heart Fail
29464808
|
52 |
13.965 |
2018 |
|
Cancer and heart failure-more than meets the eye: common risk factors and co-morbidities.
|
Eur J Heart Fail
29943887
|
19 |
13.965 |
2018 |
|
Phrenic nerve stimulation to treat patients with central sleep apnoea and heart failure.
|
Eur J Heart Fail
30303611
|
21 |
13.965 |
2018 |
|
Impact of exercise-based cardiac rehabilitation in patients with heart failure (ExTraMATCH II) on mortality and hospitalisation: an individual patient data meta-analysis of randomised trials.
|
Eur J Heart Fail
30255969
|
39 |
13.965 |
2018 |
|
Exercise training in patients with ventricular assist devices: a review of the evidence and practical advice. A position paper from the Committee on Exercise Physiology and Training and the Committee of Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology.
|
Eur J Heart Fail
30474896
|
19 |
11.627 |
2018 |
|
More variety with the Journal of Cachexia, Sarcopenia and Muscle: JCSM Clinical Reports and JCSM Rapid Communications have both gone live.
|
J Cachexia Sarcopenia Muscle
29608044
|
2 |
10.754 |
2018 |
|
Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry.
|
JACC Heart Fail
29852929
|
34 |
8.91 |
2018 |
|
GLIM criteria for the diagnosis of malnutrition - A consensus report from the global clinical nutrition community.
|
Clin Nutr
30181091
|
437 |
6.36 |
2018 |
|
Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with renin angiotensin aldosterone system inhibitors: coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology.
|
Eur Heart J Cardiovasc Pharmacother
29726985
|
35 |
3.512 |
2018 |
|
Benefits and limitations of implementing Chronic Care Model (CCM) in primary care programs: A systematic review.
|
Int J Cardiol
29544944
|
28 |
3.471 |
2018 |
|
Metabolic disorders in heart failure and cancer.
|
ESC Heart Fail
30570226
|
20 |
3.407 |
2018 |
|
GLIM Criteria for the Diagnosis of Malnutrition: A Consensus Report From the Global Clinical Nutrition Community.
|
JPEN J Parenter Enteral Nutr
30175461
|
104 |
2.853 |
2018 |
|
Cardiac Cachexia - A Window to the Wasting DisordersCardiac cachexia: perspectives for prevention and treatmentSkeletal muscle aging: influence of oxidative stress and physical exerciseCancer-induced muscle wasting: latest findings in prevention and treatmentCancer-induced cardiac cachexia: pathogenesis and impact of physical activity (Review)Muscle wasting and cachexia in heart failure: mechanisms and therapiesEffects of growth hormone on cardiac remodeling and soleus muscle in rats with aortic stenosis-induced heart failure.
|
Arq Bras Cardiol
29538532
|
1 |
1.679 |
2018 |
|
The importance of registries in today's heart failure therapies.
|
Kardiol Pol
29984809
|
0 |
1.674 |
2018 |
|
Foreword.
|
Card Fail Rev
29844923
|
0 |
0 |
2018 |
|
Foreword.
|
Card Fail Rev
30450235
|
0 |
0 |
2018 |
|
Heart Rate and Rhythm and the Benefit of Beta-Blockers in Patients With Heart Failure.
|
J Am Coll Cardiol
28467883
|
74 |
16.834 |
2017 |
|
Physical function and exercise training in older patients with heart failure.
|
Nat Rev Cardiol
28518178
|
16 |
15.162 |
2017 |
|
Role of cardiopulmonary exercise testing in clinical stratification in heart failure. A position paper from the Committee on Exercise Physiology and Training of the Heart Failure Association of the European Society of Cardiology.
|
Eur J Heart Fail
28925073
|
50 |
13.965 |
2017 |
|
Heart and brain interaction in patients with heart failure: overview and proposal for a taxonomy. A position paper from the Study Group on Heart and Brain Interaction of the Heart Failure Association.
|
Eur J Heart Fail
29280256
|
50 |
13.965 |
2017 |
|
Characteristics, treatments and 1-year prognosis of hospitalized and ambulatory heart failure patients with chronic obstructive pulmonary disease in the European Society of Cardiology Heart Failure Long-Term Registry.
|
Eur J Heart Fail
28949063
|
38 |
13.965 |
2017 |
|
Right heart dysfunction and failure in heart failure with preserved ejection fraction: mechanisms and management. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology.
|
Eur J Heart Fail
29044932
|
76 |
13.965 |
2017 |
|
Association Between Diabetes and 1-Year Adverse Clinical Outcomes in a Multinational Cohort of Ambulatory Patients With Chronic Heart Failure: Results From the ESC-HFA Heart Failure Long-Term Registry.
|
Diabetes Care
28255009
|
38 |
13.397 |
2017 |
|
Effect of beta-adrenergic blockade with carvedilol on cachexia in severe chronic heart failure: results from the COPERNICUS trial.
|
J Cachexia Sarcopenia Muscle
28244261
|
33 |
12.511 |
2017 |
|
Ethical guidelines for publishing in the journal of cachexia, sarcopenia and muscle: update 2017.
|
J Cachexia Sarcopenia Muscle
29098794
|
246 |
12.511 |
2017 |
|
The autonomic nervous system as a therapeutic target in heart failure: a scientific position statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology.
|
Eur J Heart Fail
28949064
|
47 |
10.683 |
2017 |
|
Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry.
|
Eur J Heart Fail
28386917
|
224 |
10.683 |
2017 |
|
Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart Failure Long-Term Registry.
|
Eur J Heart Fail
28463462
|
115 |
10.683 |
2017 |
|
Adverse cardiovascular outcomes in atrial fibrillation: Validation of the new 2MACE risk score.
|
Int J Cardiol
28986061
|
5 |
4.034 |
2017 |
|
Sarcopenia, cachexia, and muscle performance in heart failure: Review update 2016.
|
Int J Cardiol
28427849
|
26 |
4.034 |
2017 |
|
Cachexia therapies - the need to take a broader look.
|
Expert Opin Biol Ther
28980495
|
0 |
3.974 |
2017 |
|
Protective effects of nebivolol from oxidative stress to prevent hypertension-related target organ damage.
|
J Hum Hypertens
28252041
|
15 |
2.433 |
2017 |
|
Nutritional Status in Advanced Heart Failure and Heart Transplant Patients.
|
Rev Esp Cardiol (Engl Ed)
28274701
|
3 |
0.181 |
2017 |
|
Foreword.
|
Card Fail Rev
28785468
|
0 |
0 |
2017 |
|
Foreword.
|
Card Fail Rev
29387456
|
0 |
0 |
2017 |
|
Effect of age and sex on efficacy and tolerability of β blockers in patients with heart failure with reduced ejection fraction: individual patient data meta-analysis.
|
BMJ
27098105
|
44 |
20.785 |
2016 |
|
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.
|
Eur Heart J
27206819
|
4097 |
20.212 |
2016 |
|
In-hospital and 1-year mortality associated with diabetes in patients with acute heart failure: results from the ESC-HFA Heart Failure Long-Term Registry.
|
Eur J Heart Fail
27790816
|
50 |
10.683 |
2016 |
|
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.
|
Eur J Heart Fail
27207191
|
2070 |
6.968 |
2016 |
|
Body surface area as a prognostic marker in chronic heart failure patients: results from the Heart Failure Registry of the Heart Failure Association of the European Society of Cardiology.
|
Eur J Heart Fail
27198159
|
10 |
6.968 |
2016 |
|
Current management of patients with severe acute peripartum cardiomyopathy: practical guidance from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy.
|
Eur J Heart Fail
27338866
|
59 |
6.968 |
2016 |
|
European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions.
|
Eur J Heart Fail
27324686
|
200 |
6.968 |
2016 |
|
WITHDRAWN: Diuretics for heart failure.
|
Cochrane Database Syst Rev
27040884
|
4 |
6.264 |
2016 |
|
The incidence of all-cause, cardiovascular and respiratory disease admission among 20,252 users of lisinopril vs. perindopril: A cohort study.
|
Int J Cardiol
27362832
|
3 |
6.189 |
2016 |
|
The PARADIGM of ARNI's: Assessing reasons for non-implementation in heart failure.
|
Int J Cardiol
27038730
|
1 |
6.189 |
2016 |
|
Central sleep apnoea in heart failure--An important issue for the modern heart failure cardiologist.
|
Int J Cardiol
26971184
|
0 |
6.189 |
2016 |
|
The effectiveness of Dietary Approaches to Stop Hypertension (DASH) counselling on estimated 10-year cardiovascular risk among patients with newly diagnosed grade 1 hypertension: A randomised clinical trial.
|
Int J Cardiol
27631719
|
2 |
6.189 |
2016 |
|
Measuring therapeutic efficacy in the treatment of central sleep apnoea in patients with heart failure.
|
Int J Cardiol
26971185
|
0 |
6.189 |
2016 |
|
Telerehabilitation in heart failure patients: The evidence and the pitfalls.
|
Int J Cardiol
27390963
|
26 |
6.189 |
2016 |
|
Establishing a pragmatic framework to optimise health outcomes in heart failure and multimorbidity (ARISE-HF): A multidisciplinary position statement.
|
Int J Cardiol
27015641
|
20 |
6.189 |
2016 |
|
CSA Is Not Beneficial Long Term in Heart Failure Patients with Reduced Ejection Fraction.
|
Int J Cardiol
27825728
|
4 |
4.034 |
2016 |
|
[2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure].
|
Kardiol Pol
27748494
|
79 |
1.341 |
2016 |
|
2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure.
|
Rev Esp Cardiol (Engl Ed)
27894487
|
206 |
0.146 |
2016 |
|
Foreword.
|
Card Fail Rev
28785447
|
0 |
0 |
2016 |
|
Foreword.
|
Card Fail Rev
28785456
|
0 |
0 |
2016 |
|
Differing prognostic value of pulse pressure in patients with heart failure with reduced or preserved ejection fraction: results from the MAGGIC individual patient meta-analysis.
|
Eur Heart J
25616644
|
19 |
20.212 |
2015 |
|
Dietary counselling has no effect on cardiovascular risk factors among Chinese Grade 1 hypertensive patients: a randomized controlled trial.
|
Eur Heart J
26264550
|
15 |
20.212 |
2015 |
|
A prospective comparison of alginate-hydrogel with standard medical therapy to determine impact on functional capacity and clinical outcomes in patients with advanced heart failure (AUGMENT-HF trial).
|
Eur Heart J
26082085
|
60 |
20.212 |
2015 |
|
Evidence for partial pharmaceutical reversal of the cancer anorexia-cachexia syndrome: the case of anamorelin.
|
J Cachexia Sarcopenia Muscle
26675382
|
15 |
9.697 |
2015 |
|
Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2015.
|
J Cachexia Sarcopenia Muscle
26672494
|
172 |
9.697 |
2015 |
|
One-year follow-up results from AUGMENT-HF: a multicentre randomized controlled clinical trial of the efficacy of left ventricular augmentation with Algisyl in the treatment of heart failure.
|
Eur J Heart Fail
26555602
|
53 |
6.968 |
2015 |
|
European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society.
|
Eur J Heart Fail
26293171
|
13 |
6.968 |
2015 |
|
Is heart rate a risk marker in patients with chronic heart failure and concomitant atrial fibrillation? Results from the MAGGIC meta-analysis.
|
Eur J Heart Fail
26358762
|
13 |
6.968 |
2015 |
|
Transparency in medical research: Time for a paradigm shift.
|
Int J Cardiol
25828129
|
1 |
6.189 |
2015 |
|
Utility of the SENIORS elderly heart failure risk model applied to the RICA registry of acute heart failure.
|
Int J Cardiol
25602297
|
5 |
6.189 |
2015 |
|
Impact Factor: Vagaries, inconsistencies and illogicalities; should it be abandoned?
|
Int J Cardiol
26313865
|
1 |
6.189 |
2015 |
|
Mineralocorticoid receptor antagonists in heart failure with preserved ejection fraction (HFpEF).
|
Int J Cardiol
26404747
|
7 |
6.189 |
2015 |
|
Adaptive licensing - A way forward in the approval process of new therapeutic agents in Europe.
|
Int J Cardiol
25767018
|
1 |
6.189 |
2015 |
|
Disclosure of negative trial results. A call for action.
|
Int J Cardiol
26151710
|
3 |
6.189 |
2015 |
|
The importance of China (and Tsung O Cheng, International Consulting Editor for China) to the International Journal of Cardiology.
|
Int J Cardiol
26241635
|
0 |
6.189 |
2015 |
|
European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society.
|
Europace
26297713
|
26 |
4.521 |
2015 |
|
Effects of Physical Exercise on Cardiovascular Diseases: Biochemical, Cellular, and Organ Effects.
|
Biomed Res Int
26788512
|
1 |
2.134 |
2015 |
|
Foreword.
|
Card Fail Rev
28785433
|
0 |
0 |
2015 |
|
Exercise-based rehabilitation for heart failure: systematic review and meta-analysis.
|
Open Heart
25685361
|
66 |
0 |
2015 |
|
The Management of Heart Failure with Preserved Ejection Fraction.
|
Card Fail Rev
28785425
|
4 |
0 |
2015 |
|
Foreword.
|
Card Fail Rev
28785423
|
0 |
0 |
2015 |
|
Muscle wasting disease: a proposal for a new disease classification.
|
J Cachexia Sarcopenia Muscle
24595459
|
48 |
9.697 |
2014 |
|
Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis.
|
Lancet
25193873
|
137 |
7.453 |
2014 |
|
Cardiopulmonary exercise testing in systolic heart failure in 2014: the evolving prognostic role: a position paper from the committee on exercise physiology and training of the heart failure association of the ESC.
|
Eur J Heart Fail
25175894
|
18 |
6.968 |
2014 |
|
Influence of systolic blood pressure on clinical outcomes in elderly heart failure patients treated with nebivolol: data from the SENIORS trial.
|
Eur J Heart Fail
25044535
|
10 |
6.968 |
2014 |
|
Exercise-based rehabilitation for heart failure.
|
Cochrane Database Syst Rev
24771460
|
146 |
6.264 |
2014 |
|
Hypertensive subjects with type-2 diabetes, the sympathetic nervous system, and treatment implications.
|
Int J Cardiol
24838060
|
9 |
6.189 |
2014 |
|
Factors associated with multimorbidity and its link with poor blood pressure control among 223,286 hypertensive patients.
|
Int J Cardiol
25499379
|
16 |
6.189 |
2014 |
|
Effects of nebivolol on biomarkers in elderly patients with heart failure.
|
Int J Cardiol
24877590
|
4 |
6.189 |
2014 |
|
The incidence of cancer deaths among hypertensive patients in a large Chinese population: a cohort study.
|
Int J Cardiol
25464439
|
6 |
6.189 |
2014 |
|
Exercise training for chronic heart failure (ExTraMATCH II): protocol for an individual participant data meta-analysis.
|
Int J Cardiol
24804902
|
7 |
6.189 |
2014 |
|
Protecting the pipeline of science: openness, scientific methods and the lessons from ticagrelor and the PLATO trial.
|
Int J Cardiol
25171967
|
0 |
6.189 |
2014 |
|
The challenge of performing effective medical research in the era of healthcare data protection.
|
Int J Cardiol
25183536
|
2 |
6.189 |
2014 |
|
Do optimal prognostic thresholds in continuous physiological variables really exist? Analysis of origin of apparent thresholds, with systematic review for peak oxygen consumption, ejection fraction and BNP.
|
PLoS One
24475020
|
10 |
3.706 |
2014 |
|
Championing cardiovascular health innovation in Europe.
|
Eur Heart J
23832552
|
2 |
20.212 |
2013 |
|
The 'skeletal muscle hypothesis in heart failure' revised.
|
Eur Heart J
23297313
|
20 |
20.212 |
2013 |
|
Prevention of liver cancer cachexia-induced cardiac wasting and heart failure.
|
Eur Heart J
23990596
|
88 |
20.212 |
2013 |
|
The anabolic catabolic transforming agent (ACTA) espindolol increases muscle mass and decreases fat mass in old rats.
|
J Cachexia Sarcopenia Muscle
24272787
|
25 |
9.697 |
2013 |
|
Known and missing left ventricular ejection fraction and survival in patients with heart failure: a MAGGIC meta-analysis report.
|
Eur J Heart Fail
23803952
|
11 |
6.968 |
2013 |
|
Organization of heart failure management in European Society of Cardiology member countries: survey of the Heart Failure Association of the European Society of Cardiology in collaboration with the Heart Failure National Societies/Working Groups.
|
Eur J Heart Fail
23787723
|
27 |
6.968 |
2013 |
|
Inconsistencies in the development of the ESC Clinical Practice Guidelines for Heart Failure.
|
Int J Cardiol
23735338
|
0 |
6.189 |
2013 |
|
Tandospirone reduces wasting and improves cardiac function in experimental cancer cachexia.
|
Int J Cardiol
24207070
|
8 |
6.189 |
2013 |
|
Round table on "Current evidence and future perspectives on n-3 PUFA": publication of the Proceedings as a supplement to the International Journal of Cardiology.
|
Int J Cardiol
24176125
|
0 |
6.189 |
2013 |
|
The obesity paradox in heart failure patients with preserved versus reduced ejection fraction: a meta-analysis of individual patient data.
|
Int J Obes (Lond)
24173404
|
54 |
5.487 |
2013 |
|
Championing cardiovascular health innovation in Europe.
|
Acta Cardiol
24579447
|
0 |
0.808 |
2013 |
|
Championing cardiovascular health innovation in Europe.
|
Turk Kardiyol Dern Ars
24165001
|
0 |
0.431 |
2013 |
|
A welcome to the new journal, International Journal of Cardiology - Heart and Vessels (IJC-H + V).
|
Int J Cardiol Heart Vessel
29450152
|
0 |
0 |
2013 |
|
Individual patient data meta-analysis of beta-blockers in heart failure: rationale and design.
|
Syst Rev
23327629
|
11 |
0 |
2013 |
|
Ursodeoxycholic acid in patients with chronic heart failure: a double-blind, randomized, placebo-controlled, crossover trial.
|
J Am Coll Cardiol
22300693
|
35 |
19.896 |
2012 |
|
Research on cachexia, sarcopenia and skeletal muscle in cardiology.
|
J Cachexia Sarcopenia Muscle
23160775
|
13 |
9.697 |
2012 |
|
Effect of nebivolol on outcome in elderly patients with heart failure and atrial fibrillation: insights from SENIORS.
|
Eur J Heart Fail
22764183
|
19 |
6.968 |
2012 |
|
Gender and survival in patients with heart failure: interactions with diabetes and aetiology. Results from the MAGGIC individual patient meta-analysis.
|
Eur J Heart Fail
22402958
|
62 |
6.968 |
2012 |
|
Relationship of serum sodium concentration to mortality in a wide spectrum of heart failure patients with preserved and with reduced ejection fraction: an individual patient data meta-analysis(†): Meta-Analysis Global Group in Chronic heart failure (MAGGIC).
|
Eur J Heart Fail
22782968
|
37 |
6.968 |
2012 |
|
Renal dysfunction in patients with heart failure with preserved versus reduced ejection fraction: impact of the new Chronic Kidney Disease-Epidemiology Collaboration Group formula.
|
Circ Heart Fail
22441773
|
52 |
6.684 |
2012 |
|
Diuretics for heart failure.
|
Cochrane Database Syst Rev
22336795
|
43 |
6.264 |
2012 |
|
Cardiac biomarkers predict outcome after hospitalisation for an acute exacerbation of chronic obstructive pulmonary disease.
|
Int J Cardiol
22668800
|
24 |
6.189 |
2012 |
|
Adherence to ethical standards in publishing scientific articles: a statement from the International Journal of Cardiology.
|
Int J Cardiol
23106906
|
7 |
6.189 |
2012 |
|
Reply to the Hong-Lin Chen article on CONSORT (2010) recommendations.
|
Int J Cardiol
23138012
|
0 |
6.189 |
2012 |
|
Right ventricular long-axis response to different chronic loading conditions: its relevance to clinical symptoms.
|
Int J Cardiol
22261688
|
2 |
6.189 |
2012 |
|
The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis.
|
Eur Heart J
21821849
|
256 |
20.212 |
2011 |
|
Clinical utility of exercise training in chronic systolic heart failure.
|
Nat Rev Cardiol
21519354
|
6 |
14.299 |
2011 |
|
Albumin levels predict survival in patients with heart failure and preserved ejection fraction.
|
Eur J Heart Fail
22158777
|
68 |
6.968 |
2011 |
|
Anaemia among patients with heart failure and preserved or reduced ejection fraction: results from the SENIORS study.
|
Eur J Heart Fail
21613429
|
25 |
6.968 |
2011 |
|
Predictors of clinical outcomes in elderly patients with heart failure.
|
Eur J Heart Fail
21454299
|
39 |
6.968 |
2011 |
|
Statement on authorship and publishing ethics in the International Journal of Cardiology.
|
Int J Cardiol
22108502
|
40 |
6.189 |
2011 |
|
Sarcopenia with limited mobility: an international consensus.
|
J Am Med Dir Assoc
21640657
|
337 |
5.775 |
2011 |
|
[Chronic heart failure, nutritional status and survival].
|
Rev Esp Cardiol
21752517
|
1 |
4.485 |
2011 |
|
Ethical guidelines for authorship and publishing in the Journal of Cachexia, Sarcopenia and Muscle.
|
J Cachexia Sarcopenia Muscle
21475697
|
87 |
9.697 |
2010 |
|
Exercise training for systolic heart failure: Cochrane systematic review and meta-analysis.
|
Eur J Heart Fail
20494922
|
95 |
6.968 |
2010 |
|
Exercise based rehabilitation for heart failure.
|
Cochrane Database Syst Rev
20393935
|
53 |
6.264 |
2010 |
|
β-blockade with nebivolol for prevention of acute ischaemic events in elderly patients with heart failure.
|
Heart
21138861
|
11 |
6.059 |
2010 |
|
Influence of diabetes mellitus and hyperglycemia on prognosis in patients > or =70 years old with heart failure and effects of nebivolol (data from the Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors with heart failure [SENIORS]).
|
Am J Cardiol
20609652
|
15 |
3.398 |
2010 |
|
Reduced confounding by impaired ventilatory function with oxygen uptake efficiency slope and VE/VCO2 slope rather than peak oxygen consumption to assess exercise physiology in suspected heart failure.
|
Congest Heart Fail
21091610
|
3 |
0 |
2010 |
|
Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure).
|
J Am Coll Cardiol
19497441
|
113 |
19.896 |
2009 |
|
Heart failure: Support for exercise training in CHF.
|
Nat Rev Cardiol
19554002
|
1 |
14.299 |
2009 |
|
Efficacy and safety of nebivolol in elderly heart failure patients with impaired renal function: insights from the SENIORS trial.
|
Eur J Heart Fail
19648605
|
33 |
6.968 |
2009 |
|
Impact of sleep disordered breathing severity on hemodynamics, autonomic balance and cardiopulmonary functional status in chronic heart failure.
|
Int J Cardiol
19144429
|
1 |
6.189 |
2009 |
|
Retraction of a paper containing plagiarized material: the prognostic value of serum troponin T in unstable angina. Gökhan Cin V, Gök H, Kaptanoğlu B. Int J Cardiol. 1996 Mar;53(3):237-44.
|
Int J Cardiol
19419781
|
0 |
6.189 |
2009 |
|
Retraction of "Song ZZ, Resynchronization of the infarcted myocardium. Int J Cardiol. 2009 Jan 9. [Epub ahead of print]" containing plagiarised material.
|
Int J Cardiol
19344963
|
0 |
6.189 |
2009 |
|
C-type natriuretic peptide production by the human kidney is blunted in chronic heart failure.
|
Clin Sci (Lond)
19450232
|
4 |
4.936 |
2009 |
|
Ethical authorship and publishing.
|
Int J Cardiol
19046787
|
70 |
6.189 |
2008 |
|
The top papers by download and citations from the International Journal of Cardiology in 2007.
|
Int J Cardiol
19019469
|
0 |
6.189 |
2008 |
|
Reduced glucose transporter GLUT4 in skeletal muscle predicts insulin resistance in non-diabetic chronic heart failure patients independently of body composition.
|
Int J Cardiol
18778861
|
15 |
6.189 |
2008 |
|
Comparing the effects of white coat hypertension and sustained hypertension on mortality in a UK primary care setting.
|
Ann Fam Med
18779542
|
4 |
4.457 |
2008 |
|
Long-term cost-effectiveness analysis of nebivolol compared with standard care in elderly patients with heart failure: an individual patient-based simulation model.
|
Pharmacoeconomics
18793034
|
14 |
3.63 |
2008 |
|
Scientific deception: Retraction of a fraudulent paper.
|
Phytother Res
19067374
|
0 |
3.092 |
2008 |
|
Effect of darbepoetin alfa on exercise tolerance in anemic patients with symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled trial.
|
J Am Coll Cardiol
17306703
|
47 |
19.896 |
2007 |
|
Heart transplantation in heart failure: the prognostic importance of body mass index at time of surgery and subsequent weight changes.
|
Eur J Heart Fail
17532263
|
5 |
6.968 |
2007 |
|
Retraction of "Xue SR. Xue Y. Xue R. Carvedilol restore cardiac calcium release channel structure and function in heart failure. Int. J Cardiology. 116(2):231-5, 2007" containing plagiarised material.
|
Int J Cardiol
18158190
|
0 |
6.189 |
2007 |
|
Tolerability and dose-related effects of nebivolol in elderly patients with heart failure: data from the Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure (SENIORS) trial.
|
Am Heart J
17584562
|
21 |
4.436 |
2007 |
|
Increased metaboreceptor stimulation explains the exaggerated exercise pressor reflex seen in heart failure.
|
J Appl Physiol (1985)
17209160
|
19 |
3.351 |
2007 |
|
Diuretics for heart failure.
|
Cochrane Database Syst Rev
16437464
|
9 |
6.264 |
2006 |
|
Statin use and survival in patients with chronic heart failure--results from two observational studies with 5200 patients.
|
Int J Cardiol
16846656
|
22 |
6.189 |
2006 |
|
The epidemiology of heart failure in Australia.
|
Int J Cardiol
17046084
|
13 |
6.189 |
2006 |
|
Redefining heart failure.
|
Int J Cardiol
16581144
|
1 |
6.189 |
2006 |
|
Are beta-blockers needed in patients receiving spironolactone for severe chronic heart failure? An analysis of the COPERNICUS study.
|
Am Heart J
16368292
|
5 |
4.436 |
2006 |
|
Contemporary (post-Wills) survey of the views of Australian medical researchers: importance of funding, infrastructure and motivators for a research career.
|
Med J Aust
16336146
|
11 |
3.675 |
2006 |
|
The Research Quality Framework and its implications for health and medical research: time to take stock?
|
Med J Aust
16646748
|
2 |
3.675 |
2006 |
|
Sleep-disordered breathing in a general heart failure population: relationships to neurohumoral activation and subjective symptoms.
|
J Sleep Res
16490006
|
20 |
3.259 |
2006 |
|
Adaptive servo-ventilation and deadspace: effects on central sleep apnoea.
|
J Sleep Res
16704575
|
22 |
3.259 |
2006 |
|
Beta-adrenoceptor antagonists in elderly patients with chronic heart failure: therapeutic potential of third-generation agents.
|
Drugs Aging
16536633
|
5 |
2.769 |
2006 |
|
Enhanced prognostic value from cardiopulmonary exercise testing in chronic heart failure by non-linear analysis: oxygen uptake efficiency slope.
|
Eur Heart J
16338939
|
55 |
20.212 |
2005 |
|
Why ventilatory inefficiency matters in chronic heart failure.
|
Eur Heart J
15695528
|
2 |
20.212 |
2005 |
|
Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).
|
Eur Heart J
15642700
|
334 |
20.212 |
2005 |
|
Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure.
|
J Am Coll Cardiol
16168285
|
89 |
19.896 |
2005 |
|
Exercise training in chronic heart failure: effects on pro-inflammatory markers.
|
Eur J Heart Fail
15701465
|
20 |
6.968 |
2005 |
|
Exercise hyperventilation in chronic heart failure is not caused by systemic lactic acidosis.
|
Eur J Heart Fail
16326362
|
6 |
6.968 |
2005 |
|
Home-based exercise training modulates pro-oxidant substrates in patients with chronic heart failure.
|
Eur J Heart Fail
15701464
|
12 |
6.968 |
2005 |
|
Whole blood endotoxin responsiveness in patients with chronic heart failure: the importance of serum lipoproteins.
|
Eur J Heart Fail
15921783
|
12 |
6.968 |
2005 |
|
Cellular endotoxin desensitization in patients with severe chronic heart failure.
|
Eur J Heart Fail
16087139
|
5 |
6.968 |
2005 |
|
The anti-CD14 antibody IC14 suppresses ex vivo endotoxin stimulated tumor necrosis factor-alpha in patients with chronic heart failure.
|
Eur J Heart Fail
16337191
|
5 |
6.968 |
2005 |
|
Patient descriptions of breathlessness in heart failure.
|
Int J Cardiol
15676168
|
7 |
6.189 |
2005 |
|
Chronic heart failure with preserved left ventricular ejection fraction: diagnostic and prognostic value of left atrial size.
|
Int J Cardiol
16325283
|
30 |
6.189 |
2005 |
|
Five years of progress for international journal of cardiology.
|
Int J Cardiol
15820303
|
0 |
6.189 |
2005 |
|
Carvedilol reduces the costs of medical care in severe heart failure: an economic analysis of the COPERNICUS study applied to the United Kingdom.
|
Int J Cardiol
15820297
|
6 |
6.189 |
2005 |
|
Advances in the non-drug, non-surgical, non-device management of chronic heart failure.
|
Int J Cardiol
15820278
|
4 |
6.189 |
2005 |
|
Top of the charts: download versus citations in the International Journal of Cardiology.
|
Int J Cardiol
16214247
|
5 |
6.189 |
2005 |
|
Echocardiographic features and brain natriuretic peptides in patients presenting with heart failure and preserved systolic function.
|
Heart
16159966
|
5 |
6.059 |
2005 |
|
Association of deranged adrenal steroid metabolism with anemia in chronic heart failure.
|
Am J Cardiol
15979444
|
5 |
3.398 |
2005 |
|
Effect of CO2 inhalation on central sleep apnea and arousals from sleep.
|
Respiration
15467327
|
15 |
2.543 |
2005 |
|
Obesity paradox as a component of reverse epidemiology in heart failure.
|
Arch Intern Med
16087835
|
10 |
0 |
2005 |
|
Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH).
|
BMJ
14729656
|
238 |
20.785 |
2004 |
|
Putative contribution of prostaglandin and bradykinin to muscle reflex hyperactivity in patients on Ace-inhibitor therapy for chronic heart failure.
|
Eur Heart J
15474695
|
17 |
20.212 |
2004 |
|
Is central nervous system processing altered in patients with heart failure?
|
Eur Heart J
15172467
|
8 |
20.212 |
2004 |
|
Haemoglobin predicts survival in patients with chronic heart failure: a substudy of the ELITE II trial.
|
Eur Heart J
15191772
|
46 |
20.212 |
2004 |
|
Influence of pretreatment systolic blood pressure on the effect of carvedilol in patients with severe chronic heart failure: the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) study.
|
J Am Coll Cardiol
15093878
|
34 |
19.896 |
2004 |
|
Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial.
|
Circulation
15381643
|
79 |
19.309 |
2004 |
|
Life-years gained from defibrillator implantation: markedly nonlinear increase during 3 years of follow-up and its implications.
|
Circulation
15066946
|
15 |
19.309 |
2004 |
|
NT-proBNP in severe chronic heart failure: rationale, design and preliminary results of the COPERNICUS NT-proBNP substudy.
|
Eur J Heart Fail
14987586
|
24 |
6.968 |
2004 |
|
The epidemiological enigma of heart failure with preserved systolic function.
|
Eur J Heart Fail
14984719
|
9 |
6.968 |
2004 |
|
Exercise based rehabilitation for heart failure.
|
Cochrane Database Syst Rev
15266480
|
66 |
6.264 |
2004 |
|
Influence of valve prosthesis type on the recovery of ventricular dysfunction and subendocardial ischaemia following valve replacement for aortic stenosis.
|
Int J Cardiol
15561345
|
2 |
6.189 |
2004 |
|
Five years of progress for International Journal of Cardiology.
|
Int J Cardiol
15561316
|
0 |
6.189 |
2004 |
|
Meta-analyses of mortality and morbidity effects of an angiotensin receptor blocker in patients with chronic heart failure already receiving an ACE inhibitor (alone or with a beta-blocker).
|
Int J Cardiol
14975535
|
11 |
6.189 |
2004 |
|
Heat shock protein 70 in patients with chronic heart failure: relation to disease severity and survival.
|
Int J Cardiol
15301893
|
32 |
6.189 |
2004 |
|
Wasting of the left ventricle in patients with cardiac cachexia: a cardiovascular magnetic resonance study.
|
Int J Cardiol
15336800
|
11 |
6.189 |
2004 |
|
Effects of carvedilol on left ventricular remodelling in chronic stable heart failure: a cardiovascular magnetic resonance study.
|
Heart
15201244
|
16 |
6.059 |
2004 |
|
Anaemia and heart failure.
|
Heart
15310675
|
4 |
6.059 |
2004 |
|
Prediction of mortality in chronic heart failure from peak oxygen consumption adjusted for either body weight or lean tissue.
|
J Card Fail
15470653
|
15 |
3.765 |
2004 |
|
Differential contribution of dead space ventilation and low arterial pCO2 to exercise hyperpnea in patients with chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
|
Am J Cardiol
14759381
|
14 |
3.398 |
2004 |
|
Circulating cytokines and chemokines in acute symptomatic parvovirus B19 infection: negative association between levels of pro-inflammatory cytokines and development of B19-associated arthritis.
|
J Med Virol
15258981
|
14 |
1.935 |
2004 |
|
Cachexia in malaria and heart failure: therapeutic considerations in clinical practice.
|
Postgrad Med J
15537847
|
12 |
1.874 |
2004 |
|
The REDON alternative.
|
Occup Health Saf
15573561
|
0 |
0 |
2004 |
|
Retraction: Shamim et Al. Nonsurgical reduction of the interventricular septum in patients with hypertrophic cardiomyopathy. N Engl J Med 2002;347:1326-33.
|
N Engl J Med
12578956
|
1 |
72.406 |
2003 |
|
Effects of initiating carvedilol in patients with severe chronic heart failure: results from the COPERNICUS Study.
|
JAMA
12585949
|
51 |
44.405 |
2003 |
|
Congenital heart disease: the original heart failure syndrome.
|
Eur Heart J
12714029
|
24 |
20.212 |
2003 |
|
The relationship between cholesterol and survival in patients with chronic heart failure.
|
J Am Coll Cardiol
14662255
|
105 |
19.896 |
2003 |
|
Variability of phase shift between blood pressure and heart rate fluctuations: a marker of short-term circulation control.
|
Circulation
12860920
|
7 |
19.309 |
2003 |
|
Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance.
|
Circulation
12821550
|
310 |
19.309 |
2003 |
|
Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging.
|
Circulation
12707250
|
143 |
19.309 |
2003 |
|
Myocardial production of C-type natriuretic peptide in chronic heart failure.
|
Circulation
12566368
|
41 |
19.309 |
2003 |
|
Skeletal muscle reflex in heart failure patients: role of hydrogen.
|
Circulation
12538432
|
21 |
19.309 |
2003 |
|
Global impairment of cardiac autonomic nervous activity late after the Fontan operation.
|
Circulation
12970229
|
16 |
19.309 |
2003 |
|
Reproducibility of the measurement of the muscle ergoreflex activity in chronic heart failure.
|
Eur J Heart Fail
12921806
|
2 |
6.968 |
2003 |
|
Adult congenital heart disease in the International Journal of Cardiology.
|
Int J Cardiol
12714188
|
0 |
6.189 |
2003 |
|
The relationship between age and production of tumour necrosis factor-alpha in healthy volunteers and patients with chronic heart failure.
|
Int J Cardiol
12957752
|
7 |
6.189 |
2003 |
|
Aerobic exercise physiology in a professional rugby union team.
|
Int J Cardiol
12559537
|
5 |
6.189 |
2003 |
|
Safety and potential benefits of low dose diamorphine during exercise in patients with chronic heart failure.
|
Heart
12923038
|
10 |
6.059 |
2003 |
|
Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study.
|
Lancet
12672310
|
182 |
4.902 |
2003 |
|
Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial): randomised controlled trial.
|
Lancet
12853194
|
71 |
4.902 |
2003 |
|
Haemoglobin concentration and prognosis in new cases of heart failure.
|
Lancet
12885484
|
8 |
4.902 |
2003 |
|
Rationale for use of an exercise end point and design for the ADVANCE (A Dose evaluation of a Vasopressin ANtagonist in CHF patients undergoing Exercise) trial.
|
Am Heart J
12514672
|
9 |
4.436 |
2003 |
|
Muscle metaboreflex-induced increases in stroke volume.
|
Med Sci Sports Exerc
12569208
|
52 |
4.141 |
2003 |
|
Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity.
|
J Card Fail
12612870
|
63 |
3.765 |
2003 |
|
Effect of anemia on exercise tolerance in chronic heart failure in men.
|
Am J Cardiol
12667582
|
20 |
3.398 |
2003 |
|
Elevated circulating levels of inflammatory cytokines and bacterial endotoxin in adults with congenital heart disease.
|
Am J Cardiol
12860222
|
36 |
3.398 |
2003 |
|
Effect of carvedilol on exercise tolerance in patients with chronic heart failure and a restrictive left ventricular filling pattern.
|
Am J Cardiol
12745124
|
0 |
3.398 |
2003 |
|
Ventricular long axis function is predictive of outcome in patients with chronic heart failure secondary to non-ischemic dilated cardiomyopathy.
|
Med Sci Monit
14586270
|
1 |
1.585 |
2003 |
|
Influence of gender and reported alcohol intake on mortality in nonischemic dilated cardiomyopathy.
|
Heart Dis
12713675
|
5 |
0 |
2003 |
|
Use of carvedilol in the treatment of heart failure.
|
Hosp Med
12789738
|
0 |
0 |
2003 |
|
Nonsurgical reduction of the interventricular septum in patients with hypertrophic cardiomyopathy.
|
N Engl J Med
12397190
|
10 |
72.406 |
2002 |
|
Positive inotropy for acute heart failure complicating myocardial infarction.
|
Eur Heart J
12208215
|
0 |
20.212 |
2002 |
|
Hospitalization of patients with heart failure: a population-based study.
|
Eur Heart J
12042009
|
53 |
20.212 |
2002 |
|
Physical training modulates proinflammatory cytokines and the soluble Fas/soluble Fas ligand system in patients with chronic heart failure.
|
J Am Coll Cardiol
11849865
|
67 |
19.896 |
2002 |
|
The regulation and measurement of plasma volume in heart failure.
|
J Am Coll Cardiol
12084586
|
36 |
19.896 |
2002 |
|
Global impairment of cardiac autonomic nervous activity late after repair of tetralogy of Fallot.
|
Circulation
12354712
|
16 |
19.309 |
2002 |
|
Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease.
|
Circulation
12093776
|
81 |
19.309 |
2002 |
|
Chemical mediators of the muscle ergoreflex in chronic heart failure: a putative role for prostaglandins in reflex ventilatory control.
|
Circulation
12105161
|
27 |
19.309 |
2002 |
|
Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies.
|
Circulation
12045167
|
174 |
19.309 |
2002 |
|
Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study.
|
Circulation
12390947
|
273 |
19.309 |
2002 |
|
A qualitative study of chronic heart failure patients' understanding of their symptoms and drug therapy.
|
Eur J Heart Fail
12034153
|
29 |
6.968 |
2002 |
|
Clinical depression is common and significantly associated with reduced survival in patients with non-ischaemic heart failure.
|
Eur J Heart Fail
12167395
|
43 |
6.968 |
2002 |
|
The E-selectin SER128ARG gene polymorphism and restenosis after successful coronary angioplasty.
|
Int J Cardiol
12036529
|
7 |
6.189 |
2002 |
|
Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure (SENIORS). Rationale and design.
|
Int J Cardiol
12243852
|
10 |
6.189 |
2002 |
|
Do results of the ENABLE (Endothelin Antagonist Bosentan for Lowering Cardiac Events in Heart Failure) study spell the end for non-selective endothelin antagonism in heart failure?
|
Int J Cardiol
12208583
|
65 |
6.189 |
2002 |
|
Insulin resistance in moderate chronic heart failure is related to hyperleptinaemia, but not to norepinephrine or TNF-alpha.
|
Int J Cardiol
11959387
|
14 |
6.189 |
2002 |
|
Clinical characteristics and survival of patients with chronic heart failure and prolonged QRS duration.
|
Int J Cardiol
12419560
|
19 |
6.189 |
2002 |
|
MADIT II, the Multi-center Autonomic Defibrillator Implantation Trial II stopped early for mortality reduction, has ICD therapy earned its evidence-based credentials?
|
Int J Cardiol
11786150
|
1 |
6.189 |
2002 |
|
Omapatrilat--the story of Overture and Octave.
|
Int J Cardiol
12243845
|
15 |
6.189 |
2002 |
|
Beta-blocker therapy for dynamic left-ventricular outflow tract obstruction.
|
Int J Cardiol
12419557
|
5 |
6.189 |
2002 |
|
DANAMI-2: is primary angioplasty superior to thrombolysis in acute MI when the patient has to be transferred to an invasive centre?
|
Int J Cardiol
12208584
|
5 |
6.189 |
2002 |
|
Abnormal temporal dynamics of blood pressure and RR interval regulation in patients with chronic heart failure: relationship to baroreflex sensitivity.
|
Int J Cardiol
12243855
|
3 |
6.189 |
2002 |
|
How to RECOVER from RENAISSANCE? The significance of the results of RECOVER, RENAISSANCE, RENEWAL and ATTACH.
|
Int J Cardiol
12419548
|
86 |
6.189 |
2002 |
|
Origin of symptoms in patients with cachexia with special reference to weakness and shortness of breath.
|
Int J Cardiol
12163218
|
13 |
6.189 |
2002 |
|
Oscillatory ventilation during exercise in patients with chronic heart failure: clinical correlates and prognostic implications.
|
Chest
12006446
|
40 |
6.147 |
2002 |
|
Incremental changes in QRS duration in serial ECGs over time identify high risk elderly patients with heart failure.
|
Heart
12067942
|
23 |
6.059 |
2002 |
|
Relationship of skeletal muscle metaboreceptors in the upper and lower limbs with the respiratory control in patients with heart failure.
|
Clin Sci (Lond)
11749657
|
13 |
4.936 |
2002 |
|
Impact of periodic breathing on measurement of oxygen uptake and respiratory exchange ratio during cardiopulmonary exercise testing.
|
Clin Sci (Lond)
12444906
|
5 |
4.936 |
2002 |
|
Angiotensin type-1 receptor blockers in heart failure.
|
Prog Cardiovasc Dis
12007079
|
3 |
4.841 |
2002 |
|
A noninvasive measure of baroreflex sensitivity without blood pressure measurement.
|
Am Heart J
11868049
|
6 |
4.436 |
2002 |
|
Septal q waves as an indicator of risk of mortality in elderly patients with chronic heart failure.
|
Am Heart J
12360173
|
2 |
4.436 |
2002 |
|
Echocardiography-derived variables predict outcome in patients with nonischemic dilated cardiomyopathy with or without a restrictive filling pattern.
|
Am Heart J
12177655
|
6 |
4.436 |
2002 |
|
The cardiac component of cardiac cachexia.
|
Am Heart J
12094187
|
11 |
4.436 |
2002 |
|
Human pituitary growth hormone and cancer risk.
|
Lancet
12480468
|
0 |
4.33 |
2002 |
|
Pathophysiologic quantities of endotoxin-induced tumor necrosis factor-alpha release in whole blood from patients with chronic heart failure.
|
Am J Cardiol
12450603
|
15 |
3.398 |
2002 |
|
Effect of interleukin-10 on the production of tumor necrosis factor-alpha by peripheral blood mononuclear cells from patients with chronic heart failure.
|
Am J Cardiol
12161227
|
16 |
3.398 |
2002 |
|
What do Cochrane reviews tell us about anti-thrombotic therapy in heart failure with sinus rhythm?
|
QJM
12096145
|
0 |
3.131 |
2002 |
|
Relationship between detrended fluctuation analysis and spectral analysis of heart-rate variability.
|
Physiol Meas
12051310
|
18 |
2.058 |
2002 |
|
Treatment of heart failure.
|
Hosp Med
12212423
|
0 |
0 |
2002 |
|
Effect of carvedilol on survival in severe chronic heart failure.
|
N Engl J Med
11386263
|
538 |
72.406 |
2001 |
|
Physical training reduces peripheral markers of inflammation in patients with chronic heart failure.
|
Eur Heart J
11350112
|
84 |
20.212 |
2001 |
|
Coronary artery disease as the cause of incident heart failure in the population.
|
Eur Heart J
11161934
|
79 |
20.212 |
2001 |
|
A sympathetic heart and the art of dying.
|
Eur Heart J
11428846
|
2 |
20.212 |
2001 |
|
The role of C-type natriuretic peptide in cardiovascular medicine.
|
Eur Heart J
11428835
|
6 |
20.212 |
2001 |
|
Preservation of exercise capacity and lack of peripheral changes in asymptomatic patients with severely impaired left ventricular function.
|
Eur Heart J
11207081
|
6 |
20.212 |
2001 |
|
Failure of aldosterone suppression despite angiotensin-converting enzyme (ACE) inhibitor administration in chronic heart failure is associated with ACE DD genotype.
|
J Am Coll Cardiol
11401115
|
25 |
19.896 |
2001 |
|
Acquired growth hormone resistance in patients with chronic heart failure: implications for therapy with growth hormone.
|
J Am Coll Cardiol
11499736
|
38 |
19.896 |
2001 |
|
Enhanced ventilatory response to exercise in patients with chronic heart failure and preserved exercise tolerance: marker of abnormal cardiorespiratory reflex control and predictor of poor prognosis.
|
Circulation
11181471
|
65 |
19.309 |
2001 |
|
Muscle ergoreceptor overactivity reflects deterioration in clinical status and cardiorespiratory reflex control in chronic heart failure.
|
Circulation
11696473
|
67 |
19.309 |
2001 |
|
Peripheral chemoreceptor hypersensitivity: an ominous sign in patients with chronic heart failure.
|
Circulation
11479251
|
98 |
19.309 |
2001 |
|
Inspiratory muscle relaxation rate slows during exhaustive treadmill walking in patients with chronic heart failure.
|
Am J Respir Crit Care Med
11371408
|
2 |
13.204 |
2001 |
|
Wasting as an independent predictor of mortality in patients with cystic fibrosis.
|
Thorax
11562511
|
60 |
8.272 |
2001 |
|
The effects of angiotensin receptor antagonists on mortality and morbidity in heart failure--and an interaction with beta blockade.
|
Int J Cardiol
11150619
|
0 |
6.189 |
2001 |
|
CAPRICORN: a story of alpha allocation and beta-blockers in left ventricular dysfunction post-MI.
|
Int J Cardiol
11334653
|
3 |
6.189 |
2001 |
|
Making choices in cardiology: difficulties of rationing and equality of access.
|
Int J Cardiol
11376821
|
2 |
6.189 |
2001 |
|
Inflammatory cytokines and the possible immunological role for lipoproteins in chronic heart failure.
|
Int J Cardiol
11104867
|
32 |
6.189 |
2001 |
|
Femoral haemostasis after transcatheter therapeutic intervention: a prospective randomised study of the angio-seal device vs. the femostop device.
|
Int J Cardiol
11104879
|
6 |
6.189 |
2001 |
|
Pericardial fluid - dispensable or indispensable fluid and an example of patentable bio-diversity.
|
Int J Cardiol
11182171
|
0 |
6.189 |
2001 |
|
Exciting new drugs on the horizon - eplerenone, a selective aldosterone receptor antagonist (SARA).
|
Int J Cardiol
11532539
|
0 |
6.189 |
2001 |
|
Angiotensin receptor blockers -- finally the evidence is coming in: IDNT and RENAAL.
|
Int J Cardiol
11461726
|
1 |
6.189 |
2001 |
|
Chronic stable angina and its treatment; why Cinderella never gets to the ball?
|
Int J Cardiol
11104860
|
3 |
6.189 |
2001 |
|
Life, quality of life and choice in an ageing society.
|
Int J Cardiol
11259806
|
1 |
6.189 |
2001 |
|
Medical malpractice, murder and the academic community: trouble ahead.
|
Int J Cardiol
11399334
|
0 |
6.189 |
2001 |
|
Assessment of chemoreflex sensitivity in free breathing young subjects by correction for respiratory influence.
|
Int J Cardiol
11334660
|
3 |
6.189 |
2001 |
|
Raised urinary glucocorticoid and adrenal androgen precursors in the urine of young hypertensive patients: possible evidence for partial glucocorticoid resistance.
|
Heart
11454825
|
2 |
6.059 |
2001 |
|
Heart failure: What causes the symptoms of heart failure?
|
Heart
11602559
|
16 |
6.059 |
2001 |
|
Diagnostic exercise physiology in chronic heart failure.
|
Heart
11410554
|
0 |
6.059 |
2001 |
|
Water and sodium regulation in chronic heart failure: the role of natriuretic peptides and vasopressin.
|
Cardiovasc Res
11476740
|
21 |
5.878 |
2001 |
|
Chronic heart failure in the very elderly: clinical status, survival, and prognostic factors in 188 patients more than 70 years old.
|
Am Heart J
11431675
|
10 |
4.436 |
2001 |
|
Uric acid in cachectic and noncachectic patients with chronic heart failure: relationship to leg vascular resistance.
|
Am Heart J
11320368
|
15 |
4.436 |
2001 |
|
Leptin, insulin sensitivity and growth hormone binding protein in chronic heart failure with and without cardiac cachexia.
|
Eur J Endocrinol
11720897
|
26 |
4.101 |
2001 |
|
Effect of altering conditions of the sequence method on baroreflex sensitivity.
|
J Hypertens
11446718
|
10 |
4.085 |
2001 |
|
High tumour necrosis factor-alpha levels are associated with exercise intolerance and neurohormonal activation in chronic heart failure patients.
|
Cytokine
11500083
|
21 |
3.488 |
2001 |
|
Relation of heart rate and blood pressure turbulence following premature ventricular complexes to baroreflex sensitivity in chronic congestive heart failure.
|
Am J Cardiol
11249893
|
29 |
3.398 |
2001 |
|
Validation of a treadmill exercise test protocol with improved metabolic plateau formation in patients with chronic congestive heart failure.
|
Am J Cardiol
11377372
|
3 |
3.398 |
2001 |
|
Incremental importance of peak-exercise plasma levels of endothelin-1 and natriuretic peptides in chronic heart failure.
|
J Cardiovasc Pharmacol
11486251
|
1 |
2.247 |
2001 |
|
Exercise and heart failure.
|
Cardiol Clin
11570121
|
3 |
1.36 |
2001 |
|
Skeletal muscle training in chronic heart failure.
|
Acta Physiol Scand
11412141
|
12 |
0 |
2001 |
|
Knowledge and communication difficulties for patients with chronic heart failure: qualitative study.
|
BMJ
10977838
|
62 |
20.785 |
2000 |
|
Prognostic value of changes over time in exercise capacity and echocardiographic measurements in patients with chronic heart failure.
|
Eur Heart J
10637088
|
14 |
20.212 |
2000 |
|
Non-invasive assessment of vascular function; paradoxical vascular response to intravenous glucose in coronary heart disease.
|
Eur Heart J
10610742
|
1 |
20.212 |
2000 |
|
Cardiopulmonary exercise testing for prognosis in chronic heart failure: continuous and independent prognostic value from VE/VCO(2)slope and peak VO(2).
|
Eur Heart J
10637089
|
123 |
20.212 |
2000 |
|
Nitric oxide synthase in CHF.
|
Eur Heart J
10781358
|
0 |
20.212 |
2000 |
|
Bi-ventricular pacing in congestive cardiac failure. Current experience and future directions. The Imperial College Cardiac Electrophysiology Group.
|
Eur Heart J
10806011
|
3 |
20.212 |
2000 |
|
Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable?
|
Eur Heart J
10952828
|
303 |
20.212 |
2000 |
|
The relationship of the erythrocyte sedimentation rate to inflammatory cytokines and survival in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors.
|
J Am Coll Cardiol
10933367
|
15 |
19.896 |
2000 |
|
Qualification of the concepts of unqualified success and unmitigated failure.
|
Circulation
10715277
|
0 |
19.309 |
2000 |
|
Plasma cytokine parameters and mortality in patients with chronic heart failure.
|
Circulation
11120695
|
201 |
19.309 |
2000 |
|
Quantitative general theory for periodic breathing in chronic heart failure and its clinical implications.
|
Circulation
11056095
|
48 |
19.309 |
2000 |
|
Ventilatory capacity and exercise tolerance in patients with chronic stable heart failure.
|
Eur J Heart Fail
10742703
|
5 |
6.968 |
2000 |
|
A Rapid Access Heart Failure Clinic provides a prompt diagnosis and appropriate management of new heart failure presenting in the community.
|
Eur J Heart Fail
11113720
|
11 |
6.968 |
2000 |
|
Defects in insulin action in chronic heart failure.
|
Diabetes Obes Metab
11225653
|
1 |
6.715 |
2000 |
|
Consumer involvement in cardiovascular research: ways to combat bias and secrecy.
|
Int J Cardiol
11054499
|
0 |
6.189 |
2000 |
|
Pharmacogenomics: hope or hype?
|
Int J Cardiol
11121590
|
1 |
6.189 |
2000 |
|
Cardiopulmonary exercise parameters in relation to all-cause mortality in patients with chronic heart failure.
|
Int J Cardiol
10716136
|
6 |
6.189 |
2000 |
|
Superiority of endothelin-1 over norepinephrine in exercise-induced alterations of the conduit artery tone of the non-exercised arm in patients with chronic heart failure.
|
Int J Cardiol
10748306
|
3 |
6.189 |
2000 |
|
Clinical trials, treatment guidelines and real life.
|
Int J Cardiol
10841960
|
0 |
6.189 |
2000 |
|
Myocardial revascularisation: the search for the holy grail.
|
Int J Cardiol
10748302
|
0 |
6.189 |
2000 |
|
The role of inflammatory mediators in chronic heart failure: cytokines, nitric oxide, and endothelin-1.
|
Int J Cardiol
10646959
|
29 |
6.189 |
2000 |
|
Cardiac autonomic dysfunction in AIDS is not secondary to heart failure.
|
Int J Cardiol
10962112
|
11 |
6.189 |
2000 |
|
Cardiovascular research in the dock: a case for the defence.
|
Int J Cardiol
11077121
|
0 |
6.189 |
2000 |
|
Neurobiology of exaggerated heart oscillations during two meditative techniques.
|
Int J Cardiol
10905879
|
3 |
6.189 |
2000 |
|
Omapatrilat--the ups and downs of an exciting but complicated new drug.
|
Int J Cardiol
10854673
|
1 |
6.189 |
2000 |
|
Exercise endpoints in patients with chronic heart failure.
|
Int J Cardiol
10748312
|
4 |
6.189 |
2000 |
|
Beta-blockers - again, a lesson to us all, especially the research funding community.
|
Int J Cardiol
10817846
|
1 |
6.189 |
2000 |
|
The importance and complexity of neurohumeral over-activity in chronic heart failure
|
Int J Cardiol
10748305
|
1 |
6.189 |
2000 |
|
Inflammation, hormones, the blood and the heart; are cardiologists learning to be internists again?
|
Int J Cardiol
10716126
|
1 |
6.189 |
2000 |
|
Different response of patients with idiopathic and ischaemic dilated cardiomyopathy to exercise training.
|
Int J Cardiol
10962124
|
4 |
6.189 |
2000 |
|
True shape and area of proximal isovelocity surface area (PISA) when flow convergence is hemispherical in valvular regurgitation.
|
Int J Cardiol
10841965
|
6 |
6.189 |
2000 |
|
The effect of salbutamol on skeletal muscle in chronic heart failure.
|
Int J Cardiol
10841968
|
8 |
6.189 |
2000 |
|
Chronic heart failure in the elderly: value of cardiopulmonary exercise testing in risk stratification.
|
Heart
10648485
|
13 |
6.059 |
2000 |
|
Survival of patients with a new diagnosis of heart failure: a population based study.
|
Heart
10768897
|
104 |
6.059 |
2000 |
|
Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance.
|
J Cardiovasc Magn Reson
11545126
|
188 |
5.601 |
2000 |
|
Establishment and performance of a magnetic resonance cardiac function clinic.
|
J Cardiovasc Magn Reson
11545103
|
21 |
5.601 |
2000 |
|
Very-low-frequency oscillations in heart rate and blood pressure in periodic breathing: role of the cardiovascular limb of the hypoxic chemoreflex.
|
Clin Sci (Lond)
10918045
|
14 |
4.936 |
2000 |
|
Contribution of skeletal muscle 'ergoreceptors' in the human leg to respiratory control in chronic heart failure.
|
J Physiol
11118512
|
24 |
4.739 |
2000 |
|
Relation of changes over time in ventricular size and function to those in exercise capacity in patients with chronic heart failure.
|
Am Heart J
10783227
|
2 |
4.436 |
2000 |
|
The endotoxin-lipoprotein hypothesis.
|
Lancet
11036910
|
117 |
4.249 |
2000 |
|
Echocardiographic determinants of mortality in patients >67 years of age with chronic heart failure.
|
Am J Cardiol
10913476
|
3 |
3.398 |
2000 |
|
Oscillations in stroke volume and cardiac output arising from oscillatory ventilation in humans.
|
Exp Physiol
11187980
|
2 |
2.912 |
2000 |
|
Insulin resistance in chronic heart failure.
|
J Cardiovasc Pharmacol
11346220
|
20 |
2.247 |
2000 |
|
Gender differences in the urinary excretion rates of cortisol and androgen metabolites.
|
Ann Clin Biochem
11085621
|
12 |
2.024 |
2000 |
|
Unreliability of cardiothoracic ratio as a marker of left ventricular impairment: comparison with radionuclide ventriculography and echocardiography.
|
Postgrad Med J
10775282
|
17 |
1.874 |
2000 |
|
Clinical features, anthropometric characteristics, and racial influences on the 'white-coat effect' in a single-centre cohort of 1553 consecutive subjects undergoing routine ambulatory blood pressure monitoring.
|
Blood Press Monit
10828890
|
5 |
1.248 |
2000 |
|
The pathophysiology of chronic heart failure.
|
Perfusion
10926410
|
0 |
1.134 |
2000 |
|
Increased urinary cortisol and androgen metabolites in a young female with hypertension: partial glucocorticoid resistance syndrome.
|
Cardiology
10894920
|
1 |
0.732 |
2000 |
|
Exercise training in heart failure.
|
Curr Control Trials Cardiovasc Med
11714432
|
4 |
0 |
2000 |
|
Paramedic direct admission of heart-attack patients to coronary care unit.
|
Lancet
9872271
|
0 |
47.831 |
1999 |
|
Endotoxin and immune activation in chronic heart failure: a prospective cohort study.
|
Lancet
10359409
|
188 |
47.831 |
1999 |
|
The impact of cachexia on cardiorespiratory reflex control in chronic heart failure.
|
Eur Heart J
10543930
|
10 |
20.212 |
1999 |
|
Incidence and aetiology of heart failure; a population-based study.
|
Eur Heart J
10213345
|
146 |
20.212 |
1999 |
|
Aetiology and pathophysiological implications of oscillatory ventilation at rest and during exercise in chronic heart failure. Do Cheyne and Stokes have an important message for modern-day patients with heart failure?
|
Eur Heart J
10361046
|
9 |
20.212 |
1999 |
|
The ultimate follow-up.
|
Eur Heart J
10099901
|
0 |
20.212 |
1999 |
|
New perspectives on heart failure due to myocardial ischaemia.
|
Eur Heart J
10099919
|
4 |
20.212 |
1999 |
|
Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.
|
Eur Heart J
10208789
|
80 |
20.212 |
1999 |
|
Grading, staging and scoring of left-ventricular hypertrophy, left-ventricular dilatation, asymptomatic left-ventricular dysfunction and chronic heart failure.
|
Eur Heart J
10454974
|
0 |
20.212 |
1999 |
|
Peak VO2 et al. for prognosis in heart failure?
|
J Am Coll Cardiol
9973047
|
1 |
19.896 |
1999 |
|
Exercise training for heart failure: coming of age.
|
Circulation
10069779
|
6 |
19.309 |
1999 |
|
Oscillatory breathing patterns during wakefulness in patients with chronic heart failure: clinical implications and role of augmented peripheral chemosensitivity.
|
Circulation
10595954
|
50 |
19.309 |
1999 |
|
Pulmonary clearance of endothelin-1 on heart failure: reduced or normal?
|
Circulation
10604903
|
0 |
19.309 |
1999 |
|
Origin of oscillatory kinetics of respiratory gas exchange in chronic heart failure.
|
Circulation
10477531
|
8 |
19.309 |
1999 |
|
Handling complexity in oxygen delivery in the univentricular circulation.
|
Circulation
10402534
|
0 |
19.309 |
1999 |
|
Oxygenation in patients with a functionally univentricular circulation and complete mixing of blood: are saturation and flow interchangeable?
|
Circulation
10571980
|
4 |
19.309 |
1999 |
|
Diaphragm strength in chronic heart failure.
|
Am J Respir Crit Care Med
10430724
|
24 |
13.204 |
1999 |
|
Heart Failure 99 -- the MOXCON story.
|
Int J Cardiol
10574393
|
7 |
6.189 |
1999 |
|
Left ventricular remodelling: common process in patients with different primary myocardial disorders.
|
Int J Cardiol
10213279
|
12 |
6.189 |
1999 |
|
Central and peripheral components of chronic heart failure: determinants of exercise tolerance.
|
Int J Cardiol
10402045
|
3 |
6.189 |
1999 |
|
Three year mortality in heart failure patients with very low left ventricular ejection fractions.
|
Int J Cardiol
10501338
|
10 |
6.189 |
1999 |
|
Intraventricular conduction delay: a prognostic marker in chronic heart failure.
|
Int J Cardiol
10454306
|
50 |
6.189 |
1999 |
|
Cardiac effects of exercise rehabilitation in hemodialysis patients.
|
Int J Cardiol
10501340
|
31 |
6.189 |
1999 |
|
How high can a correlation coefficient be? Effects of limited reproducibility of common cardiological measures.
|
Int J Cardiol
10549842
|
11 |
6.189 |
1999 |
|
Cardiac cachexia: a syndrome with impaired survival and immune and neuroendocrine activation.
|
Chest
10084500
|
67 |
6.147 |
1999 |
|
Loss of the normal coupling between the anaerobic threshold and insulin sensitivity in chronic heart failure.
|
Heart
10455087
|
1 |
6.059 |
1999 |
|
The time course of haemodynamic, autonomic and skeletal muscle metabolic abnormalities following first extensive myocardial infarction in man.
|
J Mol Cell Cardiol
10525428
|
2 |
5.68 |
1999 |
|
Reproducibility of methods for assessing baroreflex sensitivity in normal controls and in patients with chronic heart failure.
|
Clin Sci (Lond)
10491352
|
19 |
4.936 |
1999 |
|
Comparison between spectral analysis and the phenylephrine method for the assessment of baroreflex sensitivity in chronic heart failure.
|
Clin Sci (Lond)
10491351
|
10 |
4.936 |
1999 |
|
A neural link to explain the "muscle hypothesis" of exercise intolerance in chronic heart failure.
|
Am Heart J
10347330
|
49 |
4.436 |
1999 |
|
White coat hypertension detected during screening of male adolescent athletes.
|
Am J Hypertens
10090352
|
12 |
3.541 |
1999 |
|
Loss of bone mineral in patients with cachexia due to chronic heart failure.
|
Am J Cardiol
10073875
|
18 |
3.398 |
1999 |
|
Effects of amiodarone on the P-wave triggered signal-averaged electrocardiogram in patients with paroxysmal atrial fibrillation and coronary artery disease.
|
Am J Cardiol
10073796
|
4 |
3.398 |
1999 |
|
Impact of periodic breathing on V(O2) and V(CO2): a quantitative approach by Fourier analysis.
|
Respir Physiol
10647868
|
3 |
0 |
1999 |
|
Is preventive medicine responsible for the increasing prevalence of heart failure?
|
Lancet
9736479
|
3 |
47.831 |
1998 |
|
Teaching heart-failure patients how to breathe.
|
Lancet
9643788
|
1 |
47.831 |
1998 |
|
Diagnosis and investigation of essential and secondary hypertension.
|
Eur Heart J
9568439
|
1 |
20.212 |
1998 |
|
Mechanical bridge to myocardial recovery.
|
Eur Heart J
9597401
|
1 |
20.212 |
1998 |
|
Uric acid in chronic heart failure: a marker of chronic inflammation.
|
Eur Heart J
9886724
|
62 |
20.212 |
1998 |
|
Overview of studies of exercise training in chronic heart failure: the need for a prospective randomized multicentre European trial.
|
Eur Heart J
9651706
|
12 |
20.212 |
1998 |
|
Growth hormone treatment in chronic heart failure: lessons from the first 99 patients.
|
Eur Heart J
9857911
|
0 |
20.212 |
1998 |
|
Cachexia in heart failure is bad for you.
|
Eur Heart J
9519307
|
1 |
20.212 |
1998 |
|
Optimizing exercise training for subgroups of patients with chronic heart failure.
|
Eur Heart J
9857947
|
2 |
20.212 |
1998 |
|
Hyperleptinaemia in chronic heart failure. Relationships with insulin.
|
Eur Heart J
9820994
|
22 |
20.212 |
1998 |
|
Angiotensin-converting enzyme (ACE) inhibitors revert abnormal right ventricular filling in patients with restrictive left ventricular disease.
|
J Am Coll Cardiol
9809924
|
9 |
19.896 |
1998 |
|
Deficient insulin-like growth factor I in chronic heart failure predicts altered body composition, anabolic deficiency, cytokine and neurohormonal activation.
|
J Am Coll Cardiol
9708466
|
40 |
19.896 |
1998 |
|
Overview and meta-analysis of randomised trials of amiodarone in chronic heart failure.
|
Int J Cardiol
9781781
|
8 |
6.189 |
1998 |
|
Is heart rate variability a reliable method to assess autonomic modulation in left ventricular dysfunction and heart failure? Assessment of autonomic modulation with heart rate variability.
|
Int J Cardiol
9880196
|
9 |
6.189 |
1998 |
|
Abnormal ventricular activation and repolarisation during dobutamine stress echocardiography in coronary artery disease.
|
Heart
9659193
|
8 |
6.059 |
1998 |
|
Echo derived variables predicting exercise tolerance in patients with dilated and poorly functioning left ventricle.
|
Heart
10065024
|
6 |
6.059 |
1998 |
|
Ventilatory response to exercise correlates with impaired heart rate variability in patients with chronic congestive heart failure.
|
Am J Cardiol
9708664
|
17 |
3.398 |
1998 |
|
Impaired baroreflex sensitivity and sympathovagal balance in syndrome X.
|
Am J Cardiol
9781968
|
12 |
3.398 |
1998 |
|
Treating chronic heart failure: time to take stock.
|
Lancet
9100617
|
4 |
47.831 |
1997 |
|
Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care.
|
Lancet
9365448
|
141 |
47.831 |
1997 |
|
Wasting as independent risk factor for mortality in chronic heart failure.
|
Lancet
9107242
|
317 |
47.831 |
1997 |
|
Dyspnoea and exercise intolerance during cardiopulmonary exercise testing in patients with univentricular heart. The effects of chronic hypoxaemia and Fontan procedure.
|
Eur Heart J
9458430
|
6 |
20.212 |
1997 |
|
Clinical characteristics of chronic heart failure patients with an augmented peripheral chemoreflex.
|
Eur Heart J
9076386
|
41 |
20.212 |
1997 |
|
Skeletal muscle abnormalities and evidence for their role in symptom generation in chronic heart failure.
|
Eur Heart J
9447313
|
14 |
20.212 |
1997 |
|
Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure.
|
Eur Heart J
9152657
|
79 |
20.212 |
1997 |
|
The influence of muscle mass, strength, fatigability and blood flow on exercise capacity in cachectic and non-cachectic patients with chronic heart failure.
|
Eur Heart J
9043843
|
34 |
20.212 |
1997 |
|
Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure.
|
J Am Coll Cardiol
9247528
|
120 |
19.896 |
1997 |
|
Effects of dihydrocodeine on chemosensitivity and exercise tolerance in patients with chronic heart failure.
|
J Am Coll Cardiol
8996307
|
33 |
19.896 |
1997 |
|
Tumor necrosis factor and steroid metabolism in chronic heart failure: possible relation to muscle wasting.
|
J Am Coll Cardiol
9316530
|
38 |
19.896 |
1997 |
|
Effects of chronic hypoxemia on chemosensitivity in patients with univentricular heart.
|
J Am Coll Cardiol
9385914
|
4 |
19.896 |
1997 |
|
Clinical correlates and prognostic significance of the ventilatory response to exercise in chronic heart failure.
|
J Am Coll Cardiol
9180123
|
93 |
19.896 |
1997 |
|
Skeletal muscle function and its relation to exercise tolerance in chronic heart failure.
|
J Am Coll Cardiol
9385904
|
117 |
19.896 |
1997 |
|
Augmented peripheral chemosensitivity as a potential input to baroreflex impairment and autonomic imbalance in chronic heart failure.
|
Circulation
9355898
|
68 |
19.309 |
1997 |
|
Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia.
|
Circulation
9244221
|
152 |
19.309 |
1997 |
|
Chemoreflexes in heart failure.
|
Circulation
9323113
|
1 |
19.309 |
1997 |
|
Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction.
|
Circulation
9008480
|
2 |
19.309 |
1997 |
|
The role of exercise training in chronic heart failure.
|
Heart
9414999
|
9 |
6.059 |
1997 |
|
Relation between serum uric acid and lower limb blood flow in patients with chronic heart failure.
|
Heart
9290400
|
14 |
6.059 |
1997 |
|
Exercise capacity in chronic heart failure is related to the aetiology of heart disease.
|
Heart
9470872
|
5 |
6.059 |
1997 |
|
The increased ventilatory response to exercise in chronic heart failure: relation to pulmonary pathology.
|
Heart
9068397
|
19 |
6.059 |
1997 |
|
Mechanical support in dilated cardiomyopathy: signs of early left ventricular recovery.
|
Ann Thorac Surg
9386694
|
4 |
3.7 |
1997 |
|
Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
|
Am J Cardiol
9202356
|
108 |
3.398 |
1997 |
|
Elevated soluble CD14 receptors and altered cytokines in chronic heart failure.
|
Am J Cardiol
9165177
|
72 |
3.398 |
1997 |
|
Effect of reduced muscle bulk on the ventilatory response to exercise in chronic congestive heart failure secondary to idiopathic dilated and ischemic cardiomyopathy.
|
Am J Cardiol
9205030
|
2 |
3.398 |
1997 |
|
Enalapril, aspirin interaction.
|
Am J Cardiol
9352997
|
1 |
3.398 |
1997 |
|
Origins of symptoms in heart failure.
|
Cardiovasc Drugs Ther
9211019
|
1 |
2.82 |
1997 |
|
Mechanisms of exercise intolerance in congestive heart failure.
|
Curr Opin Cardiol
9243079
|
9 |
2.08 |
1997 |
|
Chemoreceptor dependence of very low frequency rhythms in advanced chronic heart failure.
|
Am J Physiol
9038966
|
10 |
0 |
1997 |
|
Alveolar-capillary membrane diffusing capacity and its role in the functional capacity of chronic heart failure patients.
|
Cardiologia
9141239
|
0 |
0 |
1997 |
|
Metabolic, functional, and haemodynamic staging for CHF?
|
Lancet
8950874
|
6 |
47.831 |
1996 |
|
Heart failure patients: why do they fatigue, how do they get better?
|
Eur Heart J
8922906
|
0 |
20.212 |
1996 |
|
Chronic heart failure: a multisystem syndrome.
|
Eur Heart J
8960412
|
0 |
20.212 |
1996 |
|
Mode of death in chronic heart failure. A request and proposition for more accurate classification.
|
Eur Heart J
8880025
|
22 |
20.212 |
1996 |
|
Relation between chemosensitivity and the ventilatory response to exercise in chronic heart failure.
|
J Am Coll Cardiol
8606277
|
57 |
19.896 |
1996 |
|
Exercise limitation in chronic heart failure: central role of the periphery.
|
J Am Coll Cardiol
8890800
|
105 |
19.896 |
1996 |
|
Contribution of muscle afferents to the hemodynamic, autonomic, and ventilatory responses to exercise in patients with chronic heart failure: effects of physical training.
|
Circulation
8598085
|
128 |
19.309 |
1996 |
|
Explaining fatigue in congestive heart failure.
|
Annu Rev Med
8712779
|
22 |
13.609 |
1996 |
|
Leg blood flow, metabolism and exercise capacity in chronic stable heart failure.
|
Int J Cardiol
8842781
|
5 |
6.189 |
1996 |
|
Exercise ventilation after balloon dilatation of the mitral valve.
|
Heart
8801002
|
0 |
6.059 |
1996 |
|
Contribution of peripheral chemoreceptors to ventilation and the effects of their suppression on exercise tolerance in chronic heart failure.
|
Heart
9014795
|
23 |
6.059 |
1996 |
|
ACE inhibitors unmask incoordinate diastolic wall motion in restrictive left ventricular disease.
|
Heart
8983679
|
9 |
6.059 |
1996 |
|
Airway and cough responsiveness and exhaled nitric oxide in non-smoking patients with stable chronic heart failure.
|
Heart
8795478
|
1 |
6.059 |
1996 |
|
The "muscle hypothesis" of chronic heart failure.
|
J Mol Cell Cardiol
8938579
|
47 |
5.68 |
1996 |
|
Reproducibility of heart rate variability indices during exercise stress testing and inotrope infusion in chronic heart failure patients.
|
Clin Sci (Lond)
8813838
|
2 |
4.936 |
1996 |
|
Autonomic abnormality in chronic heart failure evaluated by heart rate variability.
|
Clin Sci (Lond)
8813837
|
1 |
4.936 |
1996 |
|
Autonomic control of skin microvessels: assessment by power spectrum of photoplethysmographic waves.
|
Clin Sci (Lond)
8665771
|
24 |
4.936 |
1996 |
|
Physical training enhances sympathetic and parasympathetic control of heart rate and peripheral vessels in chronic heart failure.
|
Clin Sci (Lond)
8813840
|
10 |
4.936 |
1996 |
|
Reproducibility of heart rate variability measures in patients with chronic heart failure.
|
Clin Sci (Lond)
8983864
|
9 |
4.936 |
1996 |
|
Peripheral chemoreflex in chronic heart failure: friend and foe.
|
Am Heart J
8831388
|
16 |
4.436 |
1996 |
|
Heart rhythms, ventricular arrhythmias, and death in chronic heart failure.
|
J Card Fail
8891855
|
6 |
3.765 |
1996 |
|
Detection and significance of a discrete very low frequency rhythm in RR interval variability in chronic congestive heart failure.
|
Am J Cardiol
8677873
|
9 |
3.398 |
1996 |
|
Transient autonomic dysfunction precedes ST-segment depression in patients with syndrome X.
|
Am J Cardiol
8644643
|
13 |
3.398 |
1996 |
|
Interruption of the progression of heart failure: are ACE inhibitors the solution?
|
Cardiology
8681315
|
2 |
1.742 |
1996 |
|
Benefits of ambulatory blood pressure monitoring in the design of antihypertensive drug trials.
|
Blood Press Monit
10226219
|
5 |
1.248 |
1996 |
|
Special section: assisted living. Meeting needs through care planning. Process and form vary by state.
|
Provider
10157193
|
0 |
0 |
1996 |
|
Heart failure trials.
|
Br J Hosp Med
8831010
|
0 |
0 |
1996 |
|
Factors which alter the relationship between ventilation and carbon dioxide production during exercise in normal subjects.
|
Eur J Appl Physiol Occup Physiol
8861683
|
1 |
0 |
1996 |
|
Nifedipine in severe aortic regurgitation.
|
N Engl J Med
7708080
|
0 |
72.406 |
1995 |
|
Basic versus applied research.
|
Lancet
7769923
|
0 |
47.831 |
1995 |
|
Severity of heart failure and dosage of angiotensin converting enzyme inhibitors.
|
BMJ
7728033
|
12 |
20.785 |
1995 |
|
The lungs in chronic heart failure.
|
Eur Heart J
7498200
|
9 |
20.212 |
1995 |
|
Reproducibility in cardiology.
|
Eur Heart J
7744083
|
0 |
20.212 |
1995 |
|
Circadian pattern of heart rate variability in chronic heart failure patients. Effects of physical training.
|
Eur Heart J
8746907
|
24 |
20.212 |
1995 |
|
Exercise intolerance in patients with chronic heart failure.
|
Eur Heart J
8881879
|
2 |
20.212 |
1995 |
|
Hypertensive microalbuminuria.
|
Hypertension
7843748
|
0 |
6.857 |
1995 |
|
Ventilation-perfusion matching in chronic heart failure.
|
Int J Cardiol
7782141
|
4 |
6.189 |
1995 |
|
Chronotropic incompetence in chronic heart failure.
|
Int J Cardiol
7649668
|
17 |
6.189 |
1995 |
|
Sympathetic stimulations by exercise-stress testing and by dobutamine infusion induce similar changes in heart rate variability in patients with chronic heart failure.
|
Clin Sci (Lond)
7554756
|
0 |
4.936 |
1995 |
|
Relationship between arterial potassium and ventilation during exercise in patients with chronic heart failure.
|
J Card Fail
9420643
|
0 |
3.765 |
1995 |
|
Skeletal muscle and the control of ventilation on exercise: evidence for metabolic receptors.
|
Eur J Clin Invest
7628515
|
14 |
2.714 |
1995 |
|
Anatomical dead space, ventilatory pattern, and exercise capacity in chronic heart failure.
|
Br Heart J
7488450
|
4 |
0 |
1995 |
|
ACE inhibitors after myocardial infarction: selection and treatment for all.
|
Br Heart J
7786644
|
3 |
0 |
1995 |
|
Inspiratory muscle strength is a determinant of maximum oxygen consumption in chronic heart failure.
|
Br Heart J
7488451
|
14 |
0 |
1995 |
|
Role of catecholamines and sympathetic activation as a risk factor for coronary artery disease.
|
J Cardiovasc Risk
7584797
|
5 |
0 |
1995 |
|
Why am I short of breath, doctor?
|
Br Heart J
7756082
|
0 |
0 |
1995 |
|
ACE inhibitors after myocardial infarction.
|
Lancet
7914583
|
1 |
47.831 |
1994 |
|
Predictors of exercise capacity in chronic heart failure.
|
Eur Heart J
8088269
|
22 |
20.212 |
1994 |
|
Efficacy of drugs in active comparison studies.
|
Eur Heart J
7698147
|
0 |
20.212 |
1994 |
|
The role of right and left ventricular function in the ventilatory response to exercise in chronic heart failure.
|
Circulation
8181130
|
10 |
19.309 |
1994 |
|
Postexercise hypotension.
|
Hypertension
8175179
|
1 |
6.857 |
1994 |
|
Effects of exercise on the autonomic control of the heart: training or overtraining?
|
Cardiovasc Res
8111786
|
1 |
5.878 |
1994 |
|
Load dependence of changes in forearm and peripheral vascular resistance after acute leg exercise in man.
|
J Physiol
7965851
|
16 |
4.739 |
1994 |
|
Within-patient correlation between the antihypertensive effects of atenolol, lisinopril and nifedipine.
|
J Hypertens
7852749
|
8 |
4.085 |
1994 |
|
Abnormal autonomic control of the cardiovascular system in syndrome X.
|
Am J Cardiol
8203334
|
19 |
3.398 |
1994 |
|
Training partially reverses skeletal muscle metabolic abnormalities during exercise in heart failure.
|
J Appl Physiol (1985)
8045834
|
25 |
3.351 |
1994 |
|
Neurohormonal mechanisms and the role of angiotensin-converting enzyme (ACE) inhibitors in heart failure.
|
Cardiovasc Drugs Ther
7873465
|
1 |
2.82 |
1994 |
|
Increased blood pressure variability during 24h blood pressure monitoring as an early sign of autonomic dysfunction in non-insulin-dependent diabetics.
|
J Hum Hypertens
7884786
|
4 |
2.797 |
1994 |
|
Accuracy of the Omron HEM 706 portable monitor for home measurement of blood pressure.
|
J Hum Hypertens
7807495
|
4 |
2.797 |
1994 |
|
New evidence for improved survival in chronic heart failure.
|
Clin Cardiol
8162626
|
0 |
2.757 |
1994 |
|
Time course of haemodynamic changes after maximal exercise.
|
Eur J Clin Invest
7705377
|
6 |
2.714 |
1994 |
|
Ventilatory efficiency is unchanged after physical training in healthy persons despite an increase exercise tolerance.
|
J Cardiovasc Risk
7621319
|
2 |
0 |
1994 |
|
Usefulness of arterial blood gas estimations during exercise in patients with chronic heart failure.
|
Br Heart J
8043331
|
11 |
0 |
1994 |
|
Effects of motivation of the patient on indices of exercise capacity in chronic heart failure.
|
Br Heart J
8130025
|
9 |
0 |
1994 |
|
Heart rate variability and clinical cardiology.
|
Br Heart J
7857748
|
0 |
0 |
1994 |
|
Symptoms and quality of life in heart failure: the muscle hypothesis.
|
Br Heart J
7946756
|
80 |
0 |
1994 |
|
Screening for hypertrophic cardiomyopathy.
|
BMJ
8461717
|
10 |
20.785 |
1993 |
|
Measurement accuracy of cardiac output in humans: indicator-dilution technique versus geometric analysis by ultrafast computed tomography.
|
J Am Coll Cardiol
8473660
|
7 |
19.896 |
1993 |
|
Physical training improves skeletal muscle metabolism in patients with chronic heart failure.
|
J Am Coll Cardiol
8459063
|
68 |
19.896 |
1993 |
|
Exercise rehabilitation in chronic heart failure.
|
J Am Coll Cardiol
8376689
|
9 |
19.896 |
1993 |
|
Bias and variability in blood pressure measurement with ambulatory recorders.
|
Hypertension
8406665
|
5 |
6.857 |
1993 |
|
Skeletal muscle blood flow in heart failure measured by ultrafast computed tomography: validation by comparison with plethysmography.
|
Cardiovasc Res
8221772
|
1 |
5.878 |
1993 |
|
Circadian blood pressure variation in diabetic patients with autonomic neuropathy.
|
J Hypertens
8258680
|
1 |
4.085 |
1993 |
|
Exercise hyperventilation chronic congestive heart failure and its relation to functional capacity and hemodynamics.
|
Am J Cardiol
8465775
|
1 |
3.398 |
1993 |
|
Persistent peripheral vasodilation and sympathetic activity in hypotension after maximal exercise.
|
J Appl Physiol (1985)
8282635
|
40 |
3.351 |
1993 |
|
Relationship between ventilation and carbon dioxide production in normal subjects with induced changes in anatomical dead space.
|
Eur J Clin Invest
8375461
|
3 |
2.714 |
1993 |
|
Second trimester ambulatory blood pressure in nulliparous pregnancy: a useful screening test for pre-eclampsia?
|
Br J Obstet Gynaecol
8217973
|
4 |
0 |
1993 |
|
Low frequency oscillations in pulmonary arterial pressure in chronic heart failure.
|
Cardioscience
8471740
|
0 |
0 |
1993 |
|
Starting treatment with angiotensin converting enzyme inhibitors in heart failure: how, where, and how much?
|
Br Heart J
8489856
|
0 |
0 |
1993 |
|
Treatment of chronic congestive heart failure.
|
N Engl J Med
1557097
|
0 |
72.406 |
1992 |
|
Increased oxygen and exercise performance in chronic heart failure.
|
Lancet
1352602
|
1 |
47.831 |
1992 |
|
Ascending aortic Doppler velocity and the prediction of exercise capacity in post-infarction left ventricular dysfunction.
|
Eur Heart J
1597222
|
0 |
20.212 |
1992 |
|
Relation between ventilation and carbon dioxide production in patients with chronic heart failure.
|
J Am Coll Cardiol
1430682
|
14 |
19.896 |
1992 |
|
Controlled trial of physical training in chronic heart failure. Exercise performance, hemodynamics, ventilation, and autonomic function.
|
Circulation
1591831
|
188 |
19.309 |
1992 |
|
Aftereffects of exercise.
|
Hypertension
1452302
|
0 |
6.857 |
1992 |
|
Ambulatory blood pressure monitoring and circadian variation of cardiovascular disease; clinical and research applications.
|
Int J Cardiol
1512052
|
2 |
6.189 |
1992 |
|
Impairment of endothelium dependent responses in a rat model of chronic heart failure: effects of an exercise training protocol.
|
Cardiovasc Res
1423434
|
6 |
5.878 |
1992 |
|
Baroreflex control of stroke volume in man: an effect mediated by the vagus.
|
J Physiol
1593476
|
15 |
4.739 |
1992 |
|
The influence of ambulatory blood pressure monitoring on the design and interpretation of trials in hypertension.
|
J Hypertens
1316405
|
8 |
4.085 |
1992 |
|
Effects of mild physical activity, atenolol and the combination on ambulatory blood pressure in hypertensive subjects.
|
J Hypertens
1335012
|
4 |
4.085 |
1992 |
|
Validation of ambulatory monitors in special populations.
|
Am J Hypertens
1303640
|
1 |
3.541 |
1992 |
|
Comparison of different methods for assessing sympathovagal balance in chronic congestive heart failure secondary to coronary artery disease.
|
Am J Cardiol
1466326
|
15 |
3.398 |
1992 |
|
Therapeutic interventions to reduce rates of hospitalization and death in patients with heart failure: new clinical evidence.
|
Cardiology
1477852
|
0 |
1.742 |
1992 |
|
Antihypertensive effect of carvedilol: a preliminary dose-response study.
|
Clin Investig
1350482
|
0 |
0 |
1992 |
|
Angiotensin-converting enzyme inhibition and physical training in heart failure.
|
J Intern Med
1658183
|
12 |
7.98 |
1991 |
|
Ambulatory blood pressure monitoring during pregnancy: validation of the TM-2420 monitor.
|
Obstet Gynecol
1984216
|
2 |
5.215 |
1991 |
|
British hypertension protocol.
|
J Hypertens
1653300
|
0 |
4.085 |
1991 |
|
Peripheral abnormalities in chronic heart failure.
|
Postgrad Med J
1924083
|
2 |
1.874 |
1991 |
|
Physical and pharmacological conditioning in chronic heart failure: a proposal for pulsed inotrope therapy.
|
Postgrad Med J
1924082
|
0 |
1.874 |
1991 |
|
Cardiac and blood pressure responses to mental stress in reactive hypertensives.
|
Clin Exp Hypertens A
2022068
|
0 |
0 |
1991 |
|
Ambulatory blood pressure monitoring in the design of antihypertensive drug trials.
|
J Hypertens Suppl
1795203
|
1 |
0 |
1991 |
|
Effects of physical training in chronic heart failure.
|
Lancet
1967416
|
66 |
47.831 |
1990 |
|
Doppler ultrasonic measurement of cardiac output: reproducibility and validation.
|
Eur Heart J
2092990
|
18 |
20.212 |
1990 |
|
Lisinopril and enalapril in hypertension: a comparative study using ambulatory monitoring.
|
J Hum Hypertens
2163450
|
6 |
2.797 |
1990 |
|
Reproducibility or variability of casual and ambulatory blood pressure data: implications for clinical trials.
|
J Hypertens Suppl
2081995
|
11 |
0 |
1990 |
|
Systemic and forearm vascular resistance changes after upright bicycle exercise in man.
|
J Physiol
2600851
|
21 |
4.739 |
1989 |
|
Ambulatory pressure monitoring in the assessment of antihypertensive therapy.
|
Cardiovasc Drugs Ther
2487802
|
7 |
2.82 |
1989 |
|
Predicting the blood pressure response to atenolol.
|
J Hum Hypertens
2724273
|
1 |
2.797 |
1989 |
|
Prosthetic heart-valve occlusion.
|
Lancet
2899251
|
0 |
47.831 |
1988 |
|
Angiotensin-converting-enzyme inhibitors in the treatment of hypertension.
|
Br J Hosp Med
2829986
|
0 |
0 |
1987 |
